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1.Introduction 
 
 
1.1. The cerebral liquor system 
 
The cerebral liquor system is filled with the cerebrospinal fluid (CSF) and can be 
classified into the inner and the outer liquor space. The outer space is confined 
outwardly by the arachnoidea and inwardly by the pia mater. The inner system is 
composed of two lateral ventricles that are connected to the third ventricle by the so-
called interventricular foramina. The third ventricle, in turn, communicates with the 
fourth ventricle via the cerebral aqueduct. In the region of the fourth ventricle, the 
CSF passes via the median and lateral apertures into the outer liquor space, from 
where it ultimately drains into the venous canals of the subarachnoidal space via 
arachnoidal villi (Kahle et al., 1990).  
 
The major sites of CSF production are the choroid plexus found in all four ventricles 
(Nicholson, 1999). These plexus, which include the choroidal epithelium, blood 
vessels and interstitial connective tissue, are the result of invaginations of the pia 
mater into the ventricular cavities (Fishman, 1992). The capillaries in the choroid 
plexus are fenestrated (Segal, 1993), while the choroidal ependymocytes are 
connected by tight junctions, thereby forming the blood/CSF barrier (Davson and 
Segal, 1996). A comparison of the constituents from both fluids demonstrates that the 
CSF is not just a plasma ultrafiltrate (Fishman, 1992). Rather, it is a product the 
secretion of which involves unidirectional ion transport processes that create an 
osmotic gradient which drives the flux of water. This is achieved by many different 
transporters on the apical and basolateral membranes of the cells of the choroid 
plexus, as well as by the expression of aquaporins  (Brown et al., 2004). 
 
Several functions are attributed to the CSF. For example, it may serve as a sink for 
metabolites and neurotransmitters from the brain parenchyma (Segal, 1993), or as a 
source for nutrients of brain cells (Johanson, 1999).  
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1.2. The ependyma 
 
The term “ependyma” originates from the greek word for upper garment (Daly et al., 
1957). It is a  single-layered epithelium that lines the ventricles of the brain and the 
central canal of the spinal cord (for review see Del Bigio, 1995) and mainly consists 
of two different cell types, namely tanycytes and “normal” ependymal cells. 
 
 
1.2.1. Tanycytes 
 
In vertebrates, tanycytes are preferentially found in the developing brain (Bruni, 
1998). In the adult mammalian brain they form the ventrolateral walls and the floor of 
the third ventricle (Akmayev et al., 1973). Characteristic for tanycytes of the ventricle 
floor are processes that project to the median eminence of the neurohypophysis, 
where they contact the blood vessel system via numerous endfeet, connecting the 
CSF and the vasculature of the neurohypophysis (Wittkowski, 1998). The tanycytes 
of the floor of the third ventricle exhibit numerous apical microvilli and membrane 
protrusions, but in general do not bear kinocilia (Rinne, 1966; Röhlich et al., 1965; 
Scott et al., 1972; Wittkowski,1967). 
 
 
1.2.2. Normal ependymal cells 
 
The quantitatively predominating “normal” ependymal cells of the ventricular 
epithelia, also called ependymocytes (Fleischhauer, 1972), are mostly of cuboidal, 
but in some regions also of columnar shape. Their most characteristic feature is a 
bundle of approximately 40 kinocilia on the apical cell surface (Manthorpe et al., 
1977). The cilia are approximately 8 µm long and project into the CSF, beating with a 
frequency of 40 Hz in the rat (O’ Callaghan et al., 1999; for further information about 
cilia, refer to section 1.6). In addition to the kinocilia, the apical surface of 
ependymocytes is often covered by microvilli. The basal end may occasionally 
extend cell processes that have to be considered rather short when compared to 
tanycytes (Junqueira and Carneiro, 1996). The ventricular ependymocytes of the 
adult rat brain do not express glial fibrillary acidic protein, but they contain the 
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intermediate filament protein vimentin (Wellard et al., 2006). Ependymocytes are 
connected via zonulae adherentes-type junctions (Brightman and Reese, 1969) as 
well as by gap junctions (Jarvis and Andrew, 1988; Yamamoto et al., 1992), which 
allows for a liquid exchange between the ventricular spaces and the interstitium of 
the brain.  
 
 
1.2.3. Ependymal development and proliferation 
 
Ependymal cells emerge from radial glia (Spassky et al., 2005). Their differentiation 
begins after birth and progresses from the region of the cerebral aqueduct (Banizs et 
al., 2005). At gestational day 10, those neuroepithelial cells of the rat brain destined 
to become ependymal cells start to proliferate (Korr, 1980). Adult ependymal cells are 
postmitotic (Spassky et al., 2005) and lack regenerative capacity (Sarnat, 1995).  
 
 
1.3. The subcommissural organ 
 
The subcommissural organ (SCO) is a small gland located in the dorso-caudal region 
of the third ventricle at the passage to the aqeduct. The cells of the SCO are 
arranged in two layers, namely the ependyma and the hypendyma, and they release 
glycoproteins into the CSF (Leonhardt, 1980; Rodriguez et al., 1992). These 
glycoproteins have a high molecular weight (Nualart et al., 1991) and aggregate to 
form the so-called Reissner’s fibre (Sterba, 1969). The function of this thread-like 
structure is unknown, as is the physiological function of the entire SCO (Rodriguez et 
al., 1998). 
 
 
1.4. Function of ependymal cells 
 
The precise roles of ependymal cells in health and disease have not yet been 
elucidated and remain mostly speculative. Nevertheless, a number of putative 
functions have been postulated and investigated, including the local mixing of the 
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CSF (Roth et al., 1985), the movement of cellular debris in the direction of CSF bulk 
flow (Cathcart and Worthington, 1964) and the secretion of components into the CSF 
(Manthorpe et al., 1977). Furthermore, the ependyma has been implicated in 
additional roles as detailed below. 
 
 
1.4.1. Involvement of the ependyma in neuron generation 
 
The idea that ependymal cells are neural precursors in the adult mammalian brain 
(Johansson et al., 1999) has been dismissed, since this stem cell function is now 
attributed to astrocytes of the subventricular zone (SVZ) located in the lateral walls of 
the lateral ventricles (Doetsch et al., 1999). These SVZ astrocytes give rise to 
neuroblasts (Doetsch et al., 1999) that migrate in the SVZ (Doetsch and Alvarez-
Buylla, 1996) in the direction of the CSF flow (Sawamoto et al., 2006). Neuroblast 
migration is directed by a spacial gradient of guidance molecules that in turn is 
created by the coordinated beating of ependymal cilia bundles (Sawamoto et al., 
2006). The migrating neuroblasts enter the olfactory bulb via the rostral migratory 
pathway, where they finally differentiate into interneurons (Doetsch and Alvarez-
Buylla, 1996; Lois and Alvarez-Buylla, 1994; Luskin, 1993). A further auxiliary 
function of ependymal cells in the process of neuron generation might be that they 
supply fuel molecules to neuronal precursors, as postulated by Verleysdonk et al. 
(2004). 
 
 
1.4.2. Involvement of ependymal cells in cerebral energy 
metabolism 
 
Ependymal cells exhibit the highest glycogen content among all cell types in the 
central nervous system (CNS; Cataldo and Broadwell, 1986; Prothmann et al., 2001), 
in conjunction with a high protein level and activity of glycogen phosphorylase 
(Cataldo and Broadwell, 1986; Pfeiffer et al., 1990). In an ependymal cell culture 
model, glycogen is degraded after addition of serotonin or noradrenaline (Prothmann 
et al., 2001). Ependymal glycogen may serve as an internal energy store that is 
mobilised in times of increased cellular energy demand. The elevated ciliary beating 
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frequency observed after serotoninergic stimulation of the ependyma (Nguyen et al., 
2001) would be an example thereof. Since ependymal cells coexpress the facilitative 
glucose transporters GLUT2 and GLUT4 besides GLUT1, as well as the enzyme 
glucokinase, they have been postulated to play a role in the brain glucose sensing 
mechanism (Maekawa et al., 2000). Cell culture experiments indeed confirmed an 
insulin-sensitive ependymal glucose uptake, although this process was found to be 
mediated by GLUT1, with insulin-like growth factor-1 as the most probable 
physiological regulator molecule (Verleysdonk et al., 2004).  
 
 
1.4.3. Participation of the ependyma in brain water and 
osmoregulation  
 
The expression of the water transport proteins aquaporin (APQ) 4 and AQP9 on 
ependymal cells (Lehmann et al., 2004) warrants the assumption that the ependyma 
may be involved in water homeostasis of the CNS (Del Bigio, 1995). AQP4 has been 
implicated in the formation of cerebral edema after ischemic injuries to the brain (e.g 
stroke; summarised by Papadopoulos et al., 2002), because AQP4 knockout mice 
exhibit reduced susceptibiliy for brain edema under this condition (Manley et al., 
2000). In addition to aquaporins, natriuretic peptides (NPs) are considered to 
modulate osmoregulation in the brain. The application of NPs to cultured ependymal 
cells or to the ependyma ex vivo elicits a rise of intracellular guanosine 3’,5’-cyclic 
monophosphate levels (Wellard et al., 2003; 2006), indicating a responsiveness of 
the ependyma toward NPs. The atrial natriuretic peptide (ANP) present in the CSF 
(Marumo et al., 1987) mainly stems from the anteroventral third ventricle (Geiger et 
al., 1989; Gundlach and Knobe, 1992) and ANP levels were observed to be 
augmented in obstructive hydrocephalus (Diringer et al., 1990). 
 
 
1.5. Hydrocephalus 
 
Hydrocephalus, the pathological dilation of the brain ventricles at the expense of 
brain parenchyma, can be classified into a communicating and a non-communicating 
form. The communicating variant is characterised by a general increase of CSF 
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volume in the ventricles due to either augmented production or impaired absorption. 
The non-communicating form can be regarded as a pathophysiological obstruction of 
the Sylvian aqueduct. It may be caused by congenital insults, tumors or infections 
(summarised by Crews et al., 2004). The medical consequences associated with 
hydrocephalus are white matter atrophy and axon damage (Gadsdon et al., 1979). 
The incidence of hydrocephalus is about 3 to 4 cases per 1000 live births (Pattisapu, 
2001), with aqueductal stenosis contributing nearly 20 % of all cases (Menkes and 
Sarnat, 2000). Several animal models are under investigation in order to discover 
genes associated with hydrocephalus (Banizs et al., 2005; Ibanez-Tallon et al., 2002; 
2004; Sapiro et al., 2002). Translation products of such genes are either direct 
constituents of the ciliary axonemal apparatus, e.g sperm-associated antigen 6 
(Spag6; Sapiro et al., 2002), polaris (Banizs et al., 2005) and Mdnah5 (Ibanez-Tallon 
et al., 2004), or they are associated with the formation and maintenance of cilia or 
cilia-bearing cells in general, as assumed for hydin (Davy and Robinson, 2003). 
Furthermore, a defect in the gene encoding the vesicular trafficking protein soluble N-
ethylmaleimide-sensitive factor (NSF)-attachment protein α (α-SNAP) is also known 
to evoke hydrocephalus (Hong et al., 2004). 
 
 
1.6. Cilia  
 
The motile ependymal cilia show the 9+2 axonemal architecture, like most other 
kinocilia and eukaryotic flagella. This structure is characterised by 9 outer 
microtubule doublets (each doublet consists of an A and a B tubule) that surround a 
central apparatus. The central apparatus is composed of two bridged, single 
microtubules encircled by the central sheath. The outer microtubule doublets are 
connected to each other by nexin links. Dynein arms attatched to the A tubules 
generate the driving force for ciliary movement by cleavage of ATP. Radial spokes 
project from the outer microtubule doublets toward the center of the axoneme. They 
are equipped with several kinases and appear to be involved in the regulation of the 
ciliary beat (Lindemann and Kanous, 1997). 
 
Cilia are rooted in basal bodies, which are derived from either centrosomes 
(Wheatley et al., 1996) or a single centriole anchored to the plasma membrane 
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(Beisson and Wright, 2003). The assembly and maintenance of cilia is accomplished 
by a process called intraflagellar transport (IFT), in which cargo particles move from 
the proximal end to the distal tip and back, driven by kinesin and dynein motor 
proteins, respectively (Rosenbaum and Witman, 2002; Snell et al., 2004).  
 
In contrast to kinocilia, immotile primary cilia lack the central apparatus and are 
devoid of force-generating constituents. They are generally assumed to have sensory 
functions (Afzelius, 2004; Ibanez-Tallon et al., 2003). 
 
 
1.7. The WD40-repeat protein family 
 
The members of the WD40-repeat protein family are characterised by the presence 
of conserved, approximately 40 amino acids long repetitive sequences in their 
primary structure, which tend to end with the amino acids tryptophan and aspartate 
(WD). These motifs, termed WD40 repeats, usually also bear the characteristic 
dipeptide glycyl-histidine (GH) 11-24 residues distant from the N-terminal start of the 
repeat sequence (Smith et al., 1999). The tertiary structure is characterised by the 
so-called β-propeller fold, comprising up to seven four-stranded β-propeller blades. 
One such blade of four β-strands is assembled from the first three β-strands of one 
WD40-sequence repeat and the last β-strand of the previous WD repeat (Li and 
Roberts, 2001). The propeller region of the WD proteins does not possess any 
catalytic activity (Neer et al.,1994). Rather, the function of WD proteins is to provide a 
structure capable of mediating protein-protein interactions (Smith et al., 1999). Thus, 
proteins of the WD-repeat family show a high degree of functional diversity despite 
the common motif (summarised in Li and Roberts, 2001).  
 
 
1.8. Subtractive cDNA libraries 
 
Suppression subtractive hybridisation is an established tool for identifying genes that 
are differentially transcribed in one tissue but not another. It can be used to generate 
subtractive cDNA libraries. To this end, mRNA from two different sources is 
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converted into cDNA. The cDNA obtained from the source to be analysed for 
differentially expressed mRNA species is named “tester” cDNA, while the cDNA 
obtained from the reference source is designated as “driver” cDNA. The driver cDNA 
is “subtracted” from the tester cDNA by hybridisation. Target cDNA sequences in the 
tester fraction are enriched by exponential PCR amplification, while the exponential 
amplification of cDNA fragments present in the tester and in the driver portion is 
prevented. The effect of suppression subtractive hybridisation is based on the cDNA 
adaptor-sequences that are ligated to the tester cDNA. Suppression PCR kinetics 
favour the attachment of PCR primers at the differentially expressed cDNA 
fragments, while non-target cDNAs either do not bear primer binding sites, only allow 
linear amplification or favour the formation of intramolecular hair-pin like structures 
hampering primer attachment and subsequently PCR amplification. For further 
molecular detail, refer to Diatchenko et al. (1996) or to the instruction manual of the 
PCR SelectTM cDNA subtraction kit. After ligation of the amplified cDNA sequences 
into plasmid vector DNA and transfection into bacteria, the resulting cDNA library 
represents gene fragments differentially transcribed in the target mRNA source.   
 
Screening of a subtractive cDNA library is accomplished by a dot blot array. The DNA 
of randomly picked clones from the library is transferred in duplicate onto nylon 
membranes and hybridised with forward and reverse-subtracted cDNA probes, 
respectively, in which digoxigenin (DIG) has been incorporated. The probe for the 
forward hybridisation is derived from the subtracted cDNA used to construct the 
library (source minus reference), whereas the probe for reverse hybridisation is made 
from subtracted cDNA for the production of which driver and tester cDNA had been 
exchanged (reference minus source). Dots of differentially expressed cDNAs are 
visualised by an anti-DIG antibody conjugated to alkaline phosphatase (AP). AP 
converts an applied chemiluminescenct substrate to its reaction product 
accompanied by the emission of light that is detected on an X-ray film. Only colonies 
which give a clear signal with the forward subtracted, but not with the reverse 
subtracted probe are considered to represent differentially expressed sequences. For 
details refer to the instruction manual of the PCR-Select differential screening kit. 
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1.9. Scope of the thesis 
 
While the existence of ependymal cells is known since 1836 (Purkinje, 1836), their 
specific roles in health and disease are not yet precisely understood. The 
identification of ependyma-specific gene expression is expected to help in elucidating 
ependymal functions. Therefore, subtractive ependymal cDNA libraries were to be 
constructed and screened in order to find differentially transcribed mRNA species. 
Candidate sequences and the respective encoded proteins were to be further 
analysed for their expression patterns and putative functions. 
Results 
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2.Results 
 
 
2.1. Identification of ependyma-specific cDNA 
fragments 
 
In order to identify genes specifically transcribed in the ependyma, a subtractive 
bovine ependymal cDNA library of ependyma minus brain and SCO minus brain was 
generated and screened as described in 1.8. and in 4.2.5. The obtained sequences 
of putative differentially expressed targets were subjected to bioinformatic analysis 
using computerized databases from the National Center for Biotechnology 
Information, Bethesda, USA (NCBI). Initially promising candidates are listed in    
Table 1, whereas unambiguous false-positives, like self-ligated vector, genomic DNA 
and clones without an ORF, are omitted. 
 
Member 1 of the solute carrier family 14 (a urea transporter; clone F3) is highly 
expressed in ependymal cells, but also in astrocytes (Berger et al., 1998). It has 
therefore not been considered further. The EF-hand domain protein corresponding to 
clone C2 is encoded by database clones from various tissues and has therefore also 
been dismissed. The protein represented by clone S38, carbonic anhydrase II, is 
predicted by SOURCE (a unification tool which dynamically collects and compiles 
data from many scientific databases, and therefore attempts to encapsulate the 
genetics and molecular biology of genes from the genomes of Homo sapiens, Mus 
musculus, Rattus norvegicus into easy to navigate gene reports; 
http://source.stanford.edu) analysis to be expressed throughout the brain and not 
exclusively in the ependyma. It was therefore not studied further. Clone E68 was 
excluded from further investigation due to the presence of Alu elements (SOURCE 
analysis), which are mobile retroposons in the human genome (El-Sawy and 
Deininger, 2005). The most promising candidate clones from the subtractive library 
screens, in terms of the aim of this thesis, are those encoding previously unknown 
ependyma-specific proteins. Since Spag6 is a known constituent of kinocilia in 
general, only E81 and C10 remain as candidates for subsequent analysis. None of 
them was chosen for further work within the scope of the present thesis, because an 
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even more interesting target had been identified in the laboratory before. Its encoded 
amino acid sequence was found to contain WD40 repeats (see 1.7). This structural 
motif mediates protein-protein interactions, and members of the WD40-repeat protein 
family exert diverse physiological functions (Smith et al, 1999; Li and Roberts, 2001). 
The underlying clone, provisionally designated Epe10, had been encountered 
multiple times in the course of several screenings of the subtracted libraries. The 
chance for it to be a false-positive was therefore deemed to be low, and it was 
selected for analysis within the work of this thesis in preference over E81 and C10. 
 
Table 1. Sequencing results from clones identified by screening the subtractive ependymal cDNA 
libraries. False-positive sequences are not listed. Rattus norveg.: Rattus norvegicus. 
 
Clone 
No 
Name 
 
Accession  
number 
Species Identification 
1 E68 AAH30277 
BAB30207 
Homo sapiens 
Mus musculus 
cDNA clone MGC40178, adult medulla  
hypothetical protein, testis 
2 E81 T43445 Homo sapiens  hypothetical protein DKFZp434A2017.1, 
 testis 
3 C2 NP_60570 
BAB24614 
Homo sapiens 
Mus musculus 
EF-hand domain (C-terminal) containing 1 
 unnamed protein product, EF-hand motif, 
 testis 
4 C10 NP_078963 Homo sapiens hypothetical protein LOC79740(FLJ23049),   
testis 
5 F3 NP_062219 Rattus norveg. solute carrier family 14 (urea transporter), 
member 1 
6 A1 NP_056588 Mus musculus Spag6 
7 S38  NP_00058 Homo sapiens carbonic anhydrase II 
 
 
2.2. Bioinformatic characterisation of Epe10/Wdr16 
 
2.2.1. Analyses of the primary and tertiary structure of 
Epe10/Wdr16 
 
The full length sequence of the rat Epe10 cDNA was obtained by 5’ and 3’ RACE and 
can be found in the Gene Bank database under the accession number DQ445463. 
The Epe10 ORF encodes a protein of 620 amino acids and a relative molecular mass 
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of 68,300. Protein motif scans reveal the Epe10 protein to bear at least eleven WD 
repeats, placing it into the WD-repeat protein family. A tertiary structure model 
obtained by threading predicts the Epe10 protein to be organised into two seven-
bladed β-propellers that are covalently linked to each other as depicted in Fig. 1. 
 
 
Fig. 1. Tertiary structure prediction for Epe10 by threading, featuring an architecture of two covalently 
linked seven-bladed β-propellers. The structure is depicted from 6 different perspectives. Each blade, 
represented by a different colour, is made up of four antiparallel β-strands. 
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2.2.2. Identification of Epe10/Wdr16 orthologs 
 
In order to identify homologs of Epe10, the nucleotide sequence databases 
deposited at the NCBI were screened with the TBLASTN program. This algorithm 
takes a protein query sequence and compares it against NCBI nucleotide databases 
translated in all six possible reading frames. The identified sequences were aligned 
on the protein level by the CLUSTALW algorithm, and the result is depicted in Fig. 2. 
In such cases where detected sequences homologous to Epe10 were not present as 
a continuous entity in the database, the full length cDNA sequences were inferred 
from those expressed sequence tags (ESTs) deposited at the NCBI that matched the 
hypothetical cDNA sequences derived from gene prediction algorithms and the 
known sequence for Epe10. In a gap-free alignment, the sequence of the human 
Wdr16 protein turns out to be identical to Epe10 in 561 out of 620 amino acids       
(90 %). In order to check for further similar genes, the human genome was scanned 
with either the Epe10 protein sequence via TBLASTN or with the human Wdr16 
mRNA sequence via BLASTN. The latter algorithm takes a nucleotide sequence and 
compares it against the NCBI nucleotide data base. The protein with the second 
highest homology after Wdr16 encoded by the human genome, as present in the 
database, corresponds to Wdr5B, the product of a gene predicted by automatic 
computational analysis. Wdr5B, although a member of the WD-repeat protein family, 
shares only 25 % identity with Epe10 on the amino acid level, a similarity exclusively 
attributable to the presence of WD repeats in both molecules. The high degree of 
similarity between rat Epe10 and human Wdr16 protein, combined with the absence 
of other sequences with a similar level of homology in the respective genomes, 
indicates orthology between these two proteins. The same is true for all proteins 
listed in Fig. 2, the minimal mutual amino acid identity of which is 40 %. Therefore 
they can be regarded as orthologs of rat Epe10 and human Wdr16. Putative Wdr16 
orthologs are found to be absent from the genomes of fungi, nematodes, 
Dictyosteliida, Entamoebidae and angiosperms. These bioinformatics-based findings 
suggest that the occurrence of Epe10 homologs is restricted to kinocilia-possessing 
organisms.    
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Fig. 2. Multiple protein sequence alignment by CLUSTALW (default parameters) of putative Wdr16 
orthologs. Genera designations are followed by the GeneBank accession numbers of the underlying 
sequences. In cases where no complete sequence was present in the database, it was assembled 
from expressed sequence tags (ESTs), indicated by “assembled”. In those cases where the database 
sequence was only predicted (GNOMON etc.), it was edited to best fit all available ESTs and the 
known sequence of Wdr16, indicated by “edited”. The Rattus sequence was determined 
experimentally. The Drosophila sequence is truncated at amino acid 684. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Phylogenetic tree of putative Wdr16 orthologs inferred by the unweighted pair group method 
with arithmetic mean (Sneath and Snokal, 1973) from the multiple protein sequence alignment 
depicted in Fig. 2. Poisson correction and pairwise gap deletion were chosen as options. 
Homogeneous patterns among lineages and uniform mutation rates among sites were assumed. The 
depicted tree is the bootstrap consensus tree of 1000 replicates. The scale bar indicates substitutions 
per nucleotide position. 
 
 
2.2.3. Analysis of the evolutionary relationship between 
Epe10/Wdr16 orthologs 
 
The evolutionary relationship between the orthologs of Epe10 was analysed by 
constructing a phylogenetic tree using the unweighted pair group method with 
arithmetic mean (Sneath and Snokal, 1973). The consensus tree of 1000 bootstrap 
replicates (Fig. 3) for the Epe10 orthologs from 15 species reproduces the commonly 
accepted evolutionary relationship between the included genera, further confirming 
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orthology for all aligned sequences. Due to the implicated gene orthology, rat Epe10 
will be referred to as Wdr16 from now on. 
 
 
2.2.4. Bioinformatic analysis of Wdr16 splice variants in  
human and rat 
 
In human beings, the wdr16 gene is located on chromosome 17 (17p12-17p13) and 
comprises 15 exons, the transcription products of which are differentially arranged in 
three splice variants identified in the nucleotide sequence database at the NCBI. The 
standard splice variant (GenBank sequence NM_001037306) that is completely 
homologous to the Epe10 cDNA sequence (accession number DQ445463) is termed 
“transcript variant 2” and comprises exons 1 - 14. The second splice variant 
represented by  EST clones, exclusively derived from human lung (accession 
numbers DA541452, BI824877 and DA269991), is devoid of exon 2 and is, for that 
reason, formed from only 13 exons. A third mRNA isoform, designated as “transcript 
variant 1” (accession number NM_145054), uses, apart from exons 2 - 14, an 
alternative exon 1 that is contained in the EST sequence DA260431. In the rat 
genome, the wdr16 ortholog localises to chromosome 10 (10q23-10q24) and 
contains only 14 exons, with the alternative exon 1 missing. While this excludes 
“transcript variant 1” from occurring in rat, the presence or absence of mRNA species 
devoid of exon 2 had to be probed experimentally (2.3.3.).  
 
 
2.2.5. Evidence for gene orthology between rat wdr16 and 
its homologous zebrafish sequence 
 
Since the experiments described in 2.12. are conducted in zebrafish embryos, it was 
desirable to obtain additional evidence for orthology between the rat and the 
zebrafish wdr16 gene.  
 
A screening of the zebrafish (Danio rerio) genome with the rat wdr16 sequence as 
the query identifies the candidate for the orthologous gene on the minus strand of 
chromosome 18 (LOC553666). The corresponding mRNA sequence can be found 
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under Gene Bank accession number NM_001020639. On the protein level, zebrafish 
and rat Wdr16 are identical in 390 out of 608 amino acids (64 %) of a gap-free 
alignment. No other sequences with comparable similarity on the protein level are 
detectable in the zebrafish genome. Regarding the organisation of Danio 
chromosome 18, LOC553666 (corresponding to wdr16) on the minus strand is 
separated by less than 5000 nucleotides from the downstream locus of syntaxin 8 
(accession number NP_956669), which in turn is located on the plus strand of the 
chromosome. This head-to-head orientation of wdr16 and syntaxin 8 is also observed 
on the respective human, rat, mouse, dog, cow and chicken chromosomes. Beyond 
the high sequence similarity, the described syntheny, also found in several other 
species, lends additional support to the postulated orthology of rat wdr16 and the 
zebrafish sequence at LOC553666. 
 
 
2.3. Analysis of the wdr16 transcription profile 
 
2.3.1. Conventional RT-PCR 
 
The tissue-specific transcription profile of the wdr16 gene was analysed by RT- PCR 
in several rat organs and cell culture systems (Fig. 4). High levels of wdr16 transcript 
were detected in 13 day-old rat ependymal primary cultures (EPC) and in testis. A 
weak signal for Wdr16 mRNA was found to be present in 21 day-old astroglial 
primary cultures (APC), lung and brain. The wdr16 transcript was not observed in 
liver, spleen, kidney, small intestine, heart or in the mouse neuroblastoma x  rat 
glioma hybrid cell line with neuronal properties, 108CC15 (Hamprecht et al., 1985). 
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Fig. 4. Ethidium bromide-stained agarose gel demonstrating the presence or absence of Wdr16 
mRNA in indicated rat tissues and in cell cultures. One microgram of total RNA was reverse-
transcribed and subjected to a PCR reaction over 30 cycles (A). As a negative control, reverse 
transcriptase was omitted (B). As a positive control, RT-PCR was carried out with primers for β-actin 
(C). The annealing temperature was 58°C for each primer pair. APC, astroglial primary culture (age 
indicated); EPC, ependymal primary culture (age indicated); 108CC15, mouse neuroblastoma x rat 
glioma hybrid cell line with neuronal properties (Hamprecht et al., 1985); ls, length standard in base 
pairs. 
 
 
2.3.2. Real-time RT-PCR 
 
The amount of Wdr16 mRNA present in various rat organs and cell cultures was 
further probed by real-time RT-PCR. The specificity of the individual reactions was 
verified by agarose gel electrophoresis and melting point analysis (not shown). A 
Wdr16-specific PCR product was obtained with RNA from brain, lung, testis, APC 
and EPC, whilst no signal was seen with samples from liver, spleen, kidney, small 
intestine and the cell line 108CC15 (not shown). 
 
In order to meaningfully compare the relative concentrations of Wdr16 mRNA in the 
different materials, the efficiencies (E) of target amplification had to be experimentally 
determined for each RNA source. For this, a dilution series was prepared from each 
RNA preparation and subjected to real-time PCR analysis. The fluorescence intensity 
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threshold crossing points (CPs) obtained from these experiments were plotted 
against the logarithms of the respective dilutions in one diagram per RNA source, 
and a straight line was obtained from these plots by linear regression analysis       
(Fig. 5). The PCR amplification efficiencies were then calculated from the slopes of 
the regression lines according to the equation E = 10 -1/slope (Table 2). In those cases 
in which the Wdr16-specific PCR product could not be obtained from the majority of 
the dilutions, the squared linear correlation coefficient (R2) remains below 0.98, 
indicating that no PCR efficiency is obtainable for the RNA source and that the target 
Wdr16 mRNA has to be assumed to be absent (Table 2; Fig. 5). 
 
PCR efficiencies derived from regression lines with R2 ≥ 0.98 were used to calculate 
the amounts of Wdr16 mRNA relative to that of the mRNA for cyclophilin as the 
standard (see Methods). The highest relative levels of Wdr16 mRNA were found in 
testis and EPC, while low amounts were detected in lung, brain and APC (Table 3). 
 
Table 2. Goodness of fit (R2) and efficiencies (E) for Wdr16 and cyclophilin directed RT-PCR resulting 
from regression lines depicted in Fig. 5. The housekeeping gene cyclophilin encodes a peptidyl-prolyl 
isomerase that is transcribed constitutively and independently from the analysed tissue and can 
therefore be used as a positive control to demonstrate the integrity of the cDNA. R2 values < 0.98 
indicate that the efficiency is not determinable (-). Efficiencies are calculated from the slope of the 
respective regression line via the equation E = 10 (–1/slope). 
 
Tissue R2 regression 
line (Wdr16) 
Efficiency 
Wdr16 
R2 regression 
line 
(cyclophilin) 
Efficiency 
cyclophilin 
EPC 0.99 1.74 0.99 1.84 
Testis 0.99 1.75 0.99 1.88 
APC 0.99 1.85 0.99 1.89 
Lung 0.99 1.94 0.99 1.93 
Brain 0.98 1.87 0.99 1.88 
Liver 0.61 - 0.99 2.04 
Kidney 0.68 - 0.99 1.92 
Spleen 0.71 - 0.99 1.88 
Intestine 0.84 - 0.99 2.00 
108CC15 0.22 - 0.99 1.95 
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Fig. 5. Results of real-time PCR analysis reflecting the presence or absence of Wdr16 mRNA in the 
indicated rat organs and cell cultures. A cDNA dilution series was generated in duplicate from each 
tissue, and each dilution was analysed by real-time PCR using Wdr16-specific (   ) and cyclophilin-
specific primers (  ), respectively. The housekeeping gene cyclophilin encodes a peptidyl-prolyl 
isomerase that is transcribed constitutively and independently from the analysed tissue and can 
therefore be used as a positive control to demonstrate the integrity of the employed cDNA. Recorded 
crossing points were plotted against log(1000/dilution factor) and subjected to a linear regression. 
Solid line, linear regression line with a goodness of fit (R2) ≥ 0.98, indicating that an RT-PCR efficiency 
could be determined and the target message was present. Dotted line, linear regression line with      
R2 < 0.98, indicating that no RT-PCR efficiency was obtainable and the target message was absent. 
The values for R2 are listed in Table 2. EPC, ependymal primary culture; APC, astroglial primary 
culture; CP, crossing point; 108CC15, mouse neuroblastoma x rat glioma hydrid cell line with neuronal 
properties (Hamprecht et al., 1985). Slopes of regression lines are listed in the order Wdr16, 
cyclophilin. Slopes of regression lines with R2 < 0.98 were considered as not determinable (n.d.).  
EPC: -4.169, -3.764; testis: -4.129, -3.645; APC: -3.736, -3.608; lung: -3.485, -3.504; brain: -3.687,               
-3.645; liver: n.d., -3.213; kidney: n.d.,-3.526; spleen: n.d., -3.651; intestine: n.d., -3.227; 1008CC15: 
n.d., -3.443.      
 
 
Table 3. Relative quantification of rat Wdr16 mRNA in tissues and cells cultures, as determined by 
real-time PCR. Values are the mean ± standard error of the mean of at least 3 independent 
determinations with separate RNA sources and expressed as % abundance of cyclophilin mRNA. The 
housekeeping gene cyclophilin encodes a peptidyl-prolyl isomerase that is transcribed constitutively 
and independently from the analysed tissue and can therefore be used as a reference to which the 
Wdr16 mRNA levels can be referred to. 
 
Testis EPC Brain Lung APC (13 d) APC (21 d) 
9.9 ± 0.9 6.6 ± 1.2 0.07 ± 0.04 0.13 ± 0.01 0.4 ± 0.1 0.71 ± 0.04 
 
 
2.3.3. Experimental investigation of putative Wdr16 splice 
variants in the rat 
 
Due to the occurrence of splice variants in humans (2.2.4.), Wdr16 mRNA from rat 
lung, testis and EPC was analysed for the inclusion of exon 2 by RT-PCR. The 
selected primer pair was expected to yield a PCR product of 170 bp in the absence 
and one of 369 bp in the presence of exon 2. Only the longer amplificate was 
detected in lung, testis and EPC (Fig. 6). For negative controls demonstrating RNA 
preparations to be free of genomic DNA, the reverse transcriptase (RT) was omitted 
in the reverse transcription (RT) reaction for each respective sample. The absence of 
an exon 2-devoid splice variant confirms the bioinformatic data (2.2.4.), indicating 
that alternative splicing, as observed in humans, is undeveloped in Rattus. 
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Fig. 6. Ethidium bromide-stained agarose gel, indicating the presence of exon 2 in Wdr16 mRNA from 
the probed rat organs and ependymal primary culture (EPC). One microgram of total RNA was 
reverse-transcribed and subsequently amplified in a PCR over 30 cycles using primers spanning intron 
2 of wdr16. The annealing temperature was 55°C. In the presence of exon 2 the expected product size 
is 369 bp, whereas a band of 170 bp would indicate the absence of exon 2. + represents the addition, 
– the omission of reverse transcriptase from the RT reaction. ls, length standard in base pairs. 
 
 
2.4. Determination of immunoreactivity and 
specificity for the Wdr16 antiserum 
 
Since it was desirable to analyse the expression of Wdr16 on the protein level, an 
antibody was raised against a peptide, the sequence of which was derived from the 
primary structure of the rat Wdr16 ortholog. The antigenic peptide 
CQAINTNEQNFLHGHGN was coupled to the immunogenic compound keyhole 
limpet hemocyanin (KLH) and sent to Charles River Laboratories for immunisation of 
guinea pigs. 
 
 
2.4.1. ELISA 
 
Only one of the two guinea pigs immunised with the peptide conjugate produced a 
Wdr16-specific antibody. The titer of the resulting antiserum was monitored by an 
ELISA over the time of the immunisation procedure. This ELISA revealed an increase 
of the antiserum titer from the first to the second immunisation that persisted until the 
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final bleeding of the animal. The preimmune serum, obtained from the animal prior to 
injection of the antigenic peptide, exhibits no affinity for Wdr16 (Fig. 7). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7. ELISA demonstrating the immunoreactivity of the guinea pig Wdr16 antiserum. A 96 well plate 
was coated with BSA conjugated to 250 ng peptide against which the antiserum was raised. Serum 
samples resulting from immunisation of a guinea pig with keyhole limpet hemocyanin-conjugated 
antigenic peptide were applied to the BSA-conjugated peptide in a dilution series ranging from 1:10 up 
to 1:106. Incubation time was 2 h. Goat anti-guinea pig IgG-alkaline phosphatase conjugate (1:1,000) 
was applied as secondary antibody for 1 h. The conjugated phosphatase converted p-
nitrophenylphosphate into the p-nitrophenolate ion, the absorbance of which was measured at a 
wavelength of 405 nm in an ELISA reader. The inflection point of the curve connecting the individual 
data points represents the titer of the respective antigenic sample.   , preimmune serum, taken from 
the animal before immunisation;    , antiserum after first boost;    ,  antiserum after second boost;  
     , antiserum after final bleeding. 
 
 
2.4.2. Western blot 
 
In the next step, the Wdr16 antiserum was checked for reactivity and specificity in 
immunoblotting experiments. Since it had been learned from PCR analyses that the 
Wdr16 mRNA is present in EPC, homogenates from this source were probed with the 
Wdr16 antiserum. Western blot analysis resulted in a single band at the relative 
molecular mass of approximately 68,000, as to be expected for Wdr16 (Fig. 8). The 
band disappeared when the antiserum was omitted, when the antiserum was 
substituted by preimmune serum, or when it was preabsorbed with the antigenic 
peptide against which it had been raised (Fig. 8). 
 
 
0 1 2 3 4 5 6 7
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
x
dilution (1:10
x
)
a
b
s
o
rb
a
n
c
e
 (
4
0
5
 n
m
)
Results 
24  
 
 
 
 
 
 
 
 
 
 
 
Fig. 8. Western blot demonstrating the monospecificity of the Wdr16 antiserum. Each lane of the gel 
was loaded with 30 µg protein from ependymal primary culture. Proteins were separated by SDS 
PAGE and transferred to a nitrocellulose membrane by electroblotting. The membrane was probed for 
1 h with guinea pig Wdr16 antiserum diluted 1:10,000 (antiserum), preimmune serum diluted 1:10,000 
(pi serum) and antiserum diluted 1:10,000 and preabsorbed with antigenic peptide (pep. abs.). In the  
“-1st” control, the antiserum was omitted. The secondary antibody used was donkey anti-guinea pig 
IgG-peroxidase conjugate diluted 1:120,000. Incubation time was 1 h. Detection was performed with 
an enhanced chemiluminescence system. M, relative molecular mass x 10-3. 
 
 
Fig. 9. Western blot showing the expression of wdr16 or lack thereof in the indicated rat tissues and in 
ependymal primary culture (EPC). Thirty micrograms of protein from each tissue sample were 
separated by SDS PAGE and transferred to a nitrocellulose membrane by electroblotting. The 
membrane was probed with guinea pig Wdr16 antiserum diluted 1:10,000 and donkey-anti guinea pig 
IgG-peroxidase conjugate diluted 1:120,000. The incubation time for each individual antibody was 1 h. 
Detection was performed by the enhanced chemiluminescence system. Replica gels were stained with 
Coomassie Brilliant Blue R250 to verify equal loading of the individual gel pockets. lc, loading control; 
M, relative molecular mass x 10-3. 
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2.5. Analysis of tissue-specific Wdr16 protein 
expression by Western blotting 
 
2.5.1. Rat tissues and cell cultures 
 
The monospecific Wdr16 antiserum was then used to probe the expression profile of 
the wdr16 gene in several adult rat tissues. The Western blot analysis depicted in 
Fig. 9 shows the presence of Wdr16 in a 13 day-old EPC and in testis, while no 
signal is visible in brain, lung, spleen, liver, kidney, heart or small intestine. 
 
 
2.5.2. Wdr16 in developing rat testis, ependymal primary 
culture and astroglial primary culture  
 
The presence of Wdr16 immunoreactivity in a 13 day-old EPC and in adult rat testis 
raised the question about the temporal onset of Wdr16 expression in the respective 
biological systems. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 10. Western blots depicting the expression of wdr16 in A, rat testis at different ages of the animal; 
B, ependymal primary cultures; and C, astroglial primary cultures over time. Thirty micrograms of 
protein from samples obtained at individual time points were separated by SDS PAGE and transferred 
to a nitrocellulose membrane by electroblotting. The membrane was probed with guinea pig Wdr16 
antiserum (1:10,000) and donkey anti-guinea pig IgG-peroxidase conjugate (1:120,000). The 
incubation time for each individual antibody was 1 h. Detection was performed by an enhanced 
chemiluminescence system. Replica gels were stained with Coomassie Brilliant Blue R250 to verify 
equal loading of the individual gel pockets. lc, loading control; * indicates a nearly homogeneous 
astroglia culture; M, relative molecular mass x 10-3.   
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According to a Western blot study (Fig. 10 A) following the time course of testis 
development from postnatal day 4 up to adulthood, Wdr16 levels begin to rise at 
approximately 24 days of age and persist until adulthood. In EPC, where the 
occurrence of the Wdr16 protein was monitored over time from day 2 up to day 13, 
immunoreactivity appears approximately from day 7 onward (Fig. 10 B). In APC, the 
Wdr16 signal increases with culture age, but the expression levels are much lower 
compared to EPC and testis. In an almost homogeneous, virtually ependymocyte-
free astroglia culture, no Wdr16 immunoreactivity is detectable (Fig. 10 C). 
 
 
2.5.3. Bull sperm 
 
The Wdr16 antiserum was expected to also recognise the orthologous bovine 
protein, because the rat sequence against which the peptide was raised differs from 
the bovine sequence in only one amino acid. Specifically, the neutral asparagine 
residue at position 55 of the rat protein is substituted by a neutral glutamine residue 
in the protein from Bos taurus. This cross-reactivity was taken advantage of by 
analysing bull semen constituents for the presence of Wdr16 by Western blotting. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 11. Separation of bull sperm into head and tail fractions. Bull sperm (A) was fractured by 
sonification (B). Pure head (C) and tail fractions (D) were enriched by centrifugation of the fractured 
sperm through a sucrose cushion. Scale bars: 50 µm. 
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Bull sperm was fractured into heads and tails by ultrasonic irradiation, followed by the 
separation of the fragments via centrifugation in a sucrose buffer. The successful 
separation is documented in Fig. 11, demonstrating both a sperm head fraction 
devoid of either contaminating tails or unseparated sperm, and a pure tail fraction. 
 
The Western blot depicted in Fig. 12 confirms the cross-reactivity of the Wdr16 
antiserum with the bovine Wdr16 ortholog. While Wdr16 immunoreactivity is not 
present in the seminal plasma and is only hardly detectable in the sperm head 
fraction, high protein levels are seen in unseparated bovine sperm, fractured sperm 
and in the sperm tail fraction (Fig. 12). 
 
Fig. 12. Western blot revealing the expression of wdr16 in bull semen constituents. Thirty micrograms 
of protein obtained from testis (t), seminal plasma (sp), sperm (s), fractured sperm (fs), sperm heads 
(sh) and sperm tails (st) were separated by SDS PAGE and transferred to a nitrocellulose membrane 
by electroblotting. The membrane was probed with guinea pig Wdr16 antiserum diluted 1:10,000 and 
donkey anti-guinea pig IgG-peroxidase conjugate diluted 1:120,000. The incubation time for each 
individual antibody was 1 h. Detection was performed by an enhanced chemiluminescence system. M, 
relative molecular mass x 10-3.  
 
 
2.5.4. HepG2 cell line 
 
The human Wdr16 ortholog has been shown to be present in the hepatocellular 
carcinoma cell line HepG2 by Silva et al. (2005). Since an antibody was not available 
to these authors, their work was restricted to the level of mRNA. Due to the cross-
reactivity of Wdr16 antiserum not only with the bovine, but also with the human 
protein, the expression of wdr16 in HepG2 cells could indeed be confirmed by 
Western blot analysis (Fig. 13). 
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Fig. 13. Western blot reflecting the expression of wdr16 in the hepatocellular carcinoma cell line 
HepG2. Proteins were separated by SDS PAGE and transferred to a nitrocellulose membrane by 
electroblotting. Thirty micrograms of protein were obtained from an ependymal primary culture (EPC) 
and from HepG2 cells (passage number 2), respectively. Proteins were separated by SDS PAGE and 
transferred to a nitrocellulose membrane by electroblotting. The membrane was probed with guinea 
pig Wdr16 antiserum (1:10,000) and donkey anti-guinea pig IgG-peroxidase conjugate (1:120,000). 
The incubation time for each individual antibody was 1 h. Detection was performed by an enhanced 
chemiluminescence system. M, relative molecular mass x 10-3. 
 
 
2.6. Analysis of mammary gland for wdr16 
expression 
 
2.6.1. Real-time RT-PCR 
 
Subjecting the Wdr16 mRNA sequence to further bioinformatic analysis via the 
bioinformatic “harvester” at the web page of the European Molecular Biology 
Laboratory (http://harvester.embl.de) yielded cDNA microchip array data 
demonstrating the wdr16 gene to be highly transcribed not only in testis, but also in 
the lactating mammary gland. The “harvester” is a search engine for the human, 
mouse and rat genomes that combines gene and protein information for target 
sequences resulting from searches of major databases and prediction servers (Liebel 
et al., 2005). Rat lactating mammary gland was analysed for presence of Wdr16 
message by real-time RT-PCR. No efficiency for Wdr16 amplification could be 
determined and Wdr16 mRNA has to be considered to be absent from lactating 
mammary gland (Fig. 14). Thus the bioinformatic data are apparently misleading.  
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Fig. 14. Real-time PCR analysis demonstrating the absence of Wdr16 mRNA from lactating mammary 
gland. A dilution series of lactating mammary gland cDNA was generated in duplicate and each 
dilution was analysed by real-time PCR using Wdr16- (   ) and cyclophilin-specific primers (   ), 
respectively. The housekeeping gene cyclophilin encodes a peptidyl-prolyl isomerase that is 
transcribed constitutively and independently from the analysed tissue and can therefore be used as a 
positive control to demonstrate the integrity of the employed cDNA. Recorded crossing points were 
plotted against log(1000/dilution factor) and subjected to a linear regression. Solid line, linear 
regression line with a goodness of fit (R2) ≥ 0.98, indicating that an RT-PCR efficiency could be 
determined and the target message was present. Dotted line, linear regression line with  R2 < 0.98 
indicating that no RT-PCR efficiency was determinable and the target message was absent. CP, 
crossing point. 
 
 
2.6.2. Western blot 
 
The lack of Wdr16 immunoreactivity in homogenates from lactating mammary gland 
further exposes the reported presence of Wdr16 message in the tissue as database 
artefact (Fig. 15). 
 
 
 
Fig. 15. Western blot demonstrating the absence of 
Wdr16 from lactating rat mammary gland. The 
indicated amounts of protein from lactating mammary 
gland (lmg) and from ependymal primary culture 
(EPC) homogenate, respectively, were separated by 
SDS PAGE and transferred to a nitrocellulose 
membrane by electroblotting. The membrane was 
probed with guinea pig Wdr16 antiserum (1:10,000) 
and donkey anti-guinea pig IgG-peroxidase conjugate 
(1:120,000). The incubation time for each individual 
antibody was 1 h. Detection was performed by an 
enhanced chemiluminescence system. Replica gels 
were stained with Coomassie Brilliant Blue R250 to 
verify equal loading of the individual gel pockets. lc, 
loading control; M, relative molecular mass x 10-3. 
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2.7. Comparison of transcription kinetics between 
wdr16, sperm-associated antigen 6, hydin and 
polaris 
 
The temporal course of wdr16 transcript levels in the developing rat testis and in 
differentiating EPCs was not only analysed by Western blotting, but also by real-time 
RT-PCR. In testis the level of Wdr16 mRNA reaches half-maximal value at an animal 
age of 25 days, as determined from the regression curve connecting the individual 
datapoints (Fig. 16 A). In the case of EPC, this occurs after 7.7 days in culture (Fig. 
16 E). In order to determine the relationship between Wdr16 and the presence of 
kinocilia, the temporal pattern of wdr16 transcription was compared to the ones of the 
genes for Spag6, a protein limited to the axoneme of kinocilia (Sapiro et al., 2000), 
for hydin, a protein exclusively expressed in kinocilia-containing tissues (Davy and 
Robinson, 2003), and for Tg737orpk (polaris), a component of the IFT apparatus 
(Haycraft et al., 2001). The efficiencies for the PCR amplification of the respective 
targets are listed in Table 4. 
 
Table 4. Goodness of fit (R2) and efficiencies (E) of the respective real-time PCR analyses of spag6, 
hydin and polaris mRNA. R2 values indicate the goodness of fit of a linear regression line connecting 
the crossing points of a cDNA dilution series from each tissue, whereby R2 ≥ 0.98 is considered to 
demonstrate linearity and therefore the generation of the PCR product. Efficiencies are calculated from 
the slope of the respective regression line via the equation E = 10 (–1/slope). 
 
Tissue 
 
R2  of 
regression 
line (Spag6) 
Efficiency 
Spag6 
R2 of 
regression 
line (hydin) 
Efficiency 
hydin 
R2 of 
regression 
line 
(polaris) 
Efficiency 
polaris 
EPC 0.99 1.68 0.99 1.89 0.99 1.96 
testis 0.98 1.66 0.99 1.95 0.99 1.98 
 
In testis as well as in EPC, the levels of Wdr16 mRNA increase at approximately the 
same time points and with practically identical time courses as the transcripts of 
spag6 and hydin (Fig. 16 A-H). The polaris transcript, however, behaves differently. 
In  testis, polaris mRNA levels increase five days prior to the levels of the messages 
for Wdr16, spag6 and hydin, i.e. on day 19 (Fig. 16 K). In EPC, the polaris mRNA 
level is found to be substantially lower and no remarkable elevation is detectable over 
time (not shown). 
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Fig. 16. Real-time PCR analysis of time-dependent change in mRNA levels for Wdr16 (A,E), hydin 
(B,F) and Spag6 (C,G) compared to cyclophilin mRNA in rat testis (A-D) and in ependymal primary 
culture (EPC; E-H), respectively. The housekeeping gene cyclophilin encodes a peptidyl-prolyl 
isomerase that is transcribed constitutively and independently from the developmental stage and can 
therefore be used as a standard to which the Wdr16 mRNA levels can be referred to. One microgram 
of total RNA was reverse-transcribed and subjected to the PCR in a LightCycler instrument over 45 
cycles using the FastStart DNA Master SYBR Green I system (for details see 4.2.10.). Each data 
point indicates the mean ± standard error of the mean of the relative amount of target mRNA 
measured in three independent rat testes and four ependymal primary cultures, respectively, at the 
indicated age. The individual data points are connected by a line obtained by computer-fitting the 
parameters of the function A=B+(P-B)(1+e(t50-t)/s)-1 to them by the method of least squares. A, relative 
abundance; B, basal level; P, plateau value; t50, time at half-maximal level; t, time;  s, slope. Overlay 
of the curves for Wdr16, hydin and Spag6 are depicted in D and H, respectively (data points omitted). 
Ordinates refer, from left to right, to Wdr16, hydin, and Spag6, respectively. The calculated t50 values 
are (in order testis, ependymal primary culture): Wdr16, 25.0 ± 0.3 and 7.7 ± 0.4; hydin, 24.4 ± 0.3 
and 7.9 ± 0.4; Spag6, 24.9 ± 0.3 and 8.4 ± 0.4 days. The R2 values represent the accuracy of the 
curve fit (in order testis, EPC): Wdr16, 0.944 and 0.758; hydin, 0.925 and 0.740; Spag6, 0.964 and 
0.880. Panel K represents figure D supplemented by the data points for tg737orpk (polaris/IFT88). The 
ordinate for polaris is the middle one. t50 for polaris is 19.2 ± 0.7, while R2 is 0.808. 
 
 
 
 
 
 
0 10 20 30 40 50 60
0
5
10
rat age (d)
re
l.
 r
a
b
u
n
d
a
n
c
e
(%
 c
y
c
lo
p
h
il
in
)
0 10 20 30 40 50 60
0.0
0.4
0.8
rat age (d)
re
l.
 a
b
u
n
d
a
n
c
e
(%
 c
y
c
lo
p
h
il
in
)
0 10 20 30 40 50 60
0.0
17.5
35.0
rat age (d)
re
l.
 a
b
u
n
d
a
n
c
e
(%
 c
y
c
lo
p
h
il
in
)
0 10 20 30 40 50 60
0
5
10
0.0
0.4
0.8
rat age (d)
re
l.
 a
b
u
n
d
a
n
c
e
(%
 c
y
c
lo
p
h
il
in
)
60
0.0
17.5
35.0
0.0 2.5 5.0 7.5 10.0 12.5 15.0
0
5
10
0.00
1.25
2.50
time in culture (d)
re
l.
 a
b
u
n
d
a
n
c
e
(%
 c
y
c
lo
p
h
il
in
)
15.0
0
10
20
0.0 2.5 5.0 7.5 10.0 12.5 15.0
0
10
20
time in culture (d)
re
l.
 a
b
u
n
d
a
n
c
e
(%
 c
y
c
lo
p
h
il
in
)
0.0 2.5 5.0 7.5 10.0 12.5 15.0
0
5
10
time in culture (d)
re
l.
 a
b
u
n
d
a
n
c
e
(%
 c
y
c
lo
p
h
il
in
)
0.0 2.5 5.0 7.5 10.0 12.5 15.0
0.0
0.5
1.0
1.5
2.0
2.5
time in culture (d)
re
l.
 a
b
u
n
d
a
n
c
e
(%
 c
y
c
lo
p
h
il
in
)
A B C
D E F
G H
0 10 20 30 40 50 60
0
5
10
0.0
0.4
0.8
rat age (d)
re
l.
 a
b
u
n
d
a
n
c
e
(%
 c
y
c
lo
p
h
il
in
)
60
0.0
17.5
35.0K
Results 
32  
2.8. Antigen affinity and specificity of Wdr16 
antiserum in immunostainings 
 
In order to analyse wdr16 expression on the cellular level, antigen affinity and 
specificity of the guinea pig Wdr16 antiserum had to be demonstrated prior to its 
application in immunocyto- and immunohistochemical labellings. 
 
Fig. 17. Immunocytochemical stainings demonstrating the antigen affinity and specificity of the guinea 
pig Wdr16 antiserum. A9 fibroblasts (passage number 42), grown on coverslips, were transfected with 
2 µg of either pEGFP-N1 vector in which the Wdr16 cDNA is fused to the N-terminus of the coding 
sequence of enhanced green fluorescent protein (rows A - C, G - I and K - M) or with the pEGFP-N1-
vector only (row D - F). Transfected cells were immunostained with Wdr16 antiserum diluted 1:1,000 
(rows A - C, D - F), preimmune serum (row G - I) or Wdr16 antiserum preabsorbed with the peptide 
against which the antiserum was raised (row K - M). The incubation time was 2 h. Goat anti-guinea pig 
IgG-Alexa 546 conjugate was used as the secondary antibody in a dilution of 1:4,000 and applied for  
1 h. Nuclei counterstained with 4’,6-diamidino-2-phenylindole are shown in column C - M. Scale bars: 
50 µm. 
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In preparation for a first experiment to demonstrate the reactivity and specifity of the 
Wdr16 antiserum in immunolabellings, the rat Wdr16 cDNA was cloned into the MCS 
of the pEGFP-N1 vector, facilitating its expression fused to the N-terminus of 
enhanced green fluorescent protein (EGFP). This fusion construct and the pEGFP-
N1 vector lacking an insert, respectively, were transfected into A9 fibroblasts 
(Littlefield, 1966). The A9 fibroblast cell line was chosen since it was readily available 
and it is known to be transfectable with commercial transfection reagents. Successful 
transfection of the cells is indicated by fluorescence due to EGFP expression (Fig. 17 
photomicrographs A, D, G, K). A9 fibroblasts transfected with the wdr16-egfp-fusion 
construct are stained by the Wdr16 antiserum (Fig. 17, row A - C), but neither by the 
corresponding preimmune serum (Fig. 17, row G - I), nor by the antiserum 
preabsorbed with the antigenic peptide against which it was raised (Fig. 17, row K - 
M). The absence of staining in fibroblasts transfected with the pEGFP-N1 vector 
lacking an insert (Fig. 17, row D - F) demonstrates that the antiserum does not react 
with the expressed EGFP tag, but specifically recognises the expressed Wdr16 
protein in immunolabelling experiments. 
 
 
2.9. Affinity purification of Wdr16 antibody  
 
2.9.1. ELISA 
 
The Wdr16 antiserum was not readily suitable for staining of EPCs due to weak 
signal intensity and high unspecific background (not shown). Thus, the guinea pig 
Wdr16 antiserum was purified using the immunogenic peptide coupled to agarose as 
an affinity matrix. After elution from the matrix, the purified antibody was subjected to 
an ELISA in order to assess its immunoreactivity towards Wdr16 and to compare its 
titer to the one of the unpurified guinea pig Wdr16 antiserum. According to this 
analysis, the purified antibody preparation maintained its titer (Fig. 18).  
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Fig. 18. ELISA demonstrating antigen recognition by the affinity-purified Wdr16 antibody. A 96 well 
plate was coated with 250 ng BSA-conjugated antigenic peptide. Affinity-purified Wdr16 antibody 
eluted from the affinity column (   ), unpurified guinea pig Wdr16 antiserum (   ) and  the preimmune 
serum (   ), repectively, were applied in a dilution series from 1:10 up to 1:106. The incubation time was 
2 h. Goat anti-guinea pig IgG-alkaline phosphatase conjugate (1:1,000) was applied as secondary 
antibody for 1 h. The product of enzymatic cleavage of p-nitrophenylphosphate was measured at a 
wavelength of 405 nm in an ELISA reader.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 19. Western blot displaying the immunoreactivity of the affinity-purified Wdr16 antibody. The 
proteins were separated by SDS PAGE and transferred to a nitrocellulose membrane by 
electroblotting. Each lane of a 10 % denaturing polyacrylamide gel was loaded with 30 µg of protein 
from an ependymal primary culture homogenate. The membrane was then probed for 1 h with 
unpurified guinea pig Wdr16 antiserum (antiserum), affinity-purified Wdr16 antibody (Wdr16-Affi), the 
flowthrough of the column used in the affinity purification (flowthrough) and the affinity-purified Wdr16 
antibody preabsorbed with the antigenic peptide (Affi-pre abs.), respectively. The dilution was 1:10,000 
with respect to the original serum in each case. The secondary antibody used was donkey-anti guinea 
pig IgG-peroxidase conjugate, diluted 1:120,000. Secondary antibody incubation time was 1 h. 
Detection was performed with an enhanced chemiluninescence system. M,  relative molecular mass x 
10-3 . 
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2.9.2. Western Blot 
 
Furthermore, the purified Wdr16 antibody was used in Western blotting experiments 
with EPC homogenate to verify its maintained antigen affinity (Fig. 19). Like the 
guinea pig Wdr16 antiserum, application of the affinity-purified Wdr16 antibody also 
resulted in a band corresponding to the relative molecular mass of Wdr16 
(approximately 68,000). The affinity column flow-through, however, did not show any 
immunoreactivity (Fig. 19). 
 
 
2.10. Immunostaining of cell cultures 
 
2.10.1. Immunostaining of ependymal primary culture for 
Wdr16 
 
The purified Wdr16 antibody was employed to analyse the expression of wdr16 in 13 
day-old EPCs by indirect immunofluorescent labelling (Fig. 20).  
 
 
 
 
 
 
Fig. 20. Immunocytochemical stainings to demonstrate 
reactivity and specificity of the affinity-purified Wdr16 antibody 
in rat ependymal primary culture. Paraformaldehyde-fixed cells 
on a coverslip were treated with purified Wdr16 antibody diluted 
1:200 (A), preimmune serum (B) and purified Wdr16 antibody 
preabsorbed with the peptide against which the antibody was 
raised (C), respectively. Incubation time was 30 min. The 
secondary antibody, donkey anti-guinea pig IgG-Cy3 conjugate, 
was diluted 1:1,000 and applied for 50 min. The Wdr16 
immunoreactivity is indicated by red fluorescence; nuclei 
appear blue due to staining with 4’,6-diamidino-2-phenylindole. 
Scale bars: 50 µm. 
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A signal due to Wdr16 immunoreactivity was seen in the cytosol of cells of an EPC 
after application of the antiserum, while it remained absent when either the 
preimmune serum or the antiserum preabsorbed with antigenic peptide was 
employed. It can be concluded that the affinity purification yielded a reactive and 
specific Wdr16 antibody which may serve as a tool for studying the spatial and 
temporal expression of wdr16 on the cellular level. 
 
 
2.10.2. Immunocytochemical double stainings of 
ependymal primary cultures and astroglial primary 
cultures for Wdr16 and α-tubulin  
 
To clarify whether the Wdr16-positive cell clusters observed in EPC are indeed  
ependymal cells, immunofluorescent double stainings were performed using the 
Wdr16 antibody in combination with a monoclonal antibody directed against α-
tubulin. Since α-tubulin is abundantly present in the ciliary axoneme, it can be used 
as a cilliary marker (Prothmann et al., 2001). The localisation of Wdr16 in the cytosol 
of kinocilia-bearing cells within an EPC is depicted in Fig. 21 A. This finding indicates 
that the Wdr16 signal stems from ependymal cells, since all other cell types possibly 
present as contaminants in EPCs are devoid of kinocilia. Thus, while unciliated cells 
and cells bearing a solitary, primary-like cilium do not show any Wdr16 
immunoreactivity, polyciliated, kinocilia-bearing cells express the Wdr16 protein (Fig. 
21 A - B).  
 
APCs are known to be contaminated with ependymal cells. When such APCs were 
subjected to immunofluorescent double labelling using the purified Wdr16 antibody 
and a monoclonal anti-α-tubulin antibody for counterstaining of cilia, solely ciliated 
ependymal islands were found to express wdr16. The signal was absent from all 
other non-ciliated cells surrounding the scattered immunopositive cell clusters (Fig. 
21 C). 
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2.10.3. Immunocytochemical double stainings of primary 
cultures for Wdr16 and the brain isoform of 
glycogen phosphorylase 
 
In ependymal cells, kinocilia are known to be colocalised with the brain isoform of 
glycogen phosphorylase (GP BB; Verleysdonk et al., 2005). GP BB is therefore 
expected to be colocalised with Wdr16 in view of the results listed above. This is 
indeed the case (Fig. 21 D). 
 
Fig. 21. Immunocytochemical double stainings for Wdr16 and α-tubulin (A-C) or brain isoform of 
glycogen phosphorylase (GP BB; D) in rat brain primary cultures. Paraformaldehyde-fixed cells on a 
coverslip were stained with Wdr16 antibody (1:200) and donkey anti-guinea pig IgG-carbocyanin 3 
conjugate (1:1,000) to indicate the presence of Wdr16 (red). For double labellings, two consecutive 
stainings with in-between fixation were performed. The antibodies used for counterstaining of cilia 
(green) were mouse monoclonal anti-α-tubulin antibody (1:1,000) and rabbit anti-mouse IgG-
fluorescein isothiocyanate conjugate (1:2,000). The counterstaining for GP BB (green) was performed 
with rabbit anti-glycogen phosphorylase antiserum (1:1,000) in combination with goat anti-rabbit IgG-
Alexa 488 conjugate (1:1,000). Incubation times were 30 min each for the first antibodies, and 50 min 
each for the secondary antibodies. Nuclei were counterstained with 4’,6-diamidino-2-phenylindole 
(blue). A, 13 d old ependymal primary culture stained for Wdr16 (red) and α-tubulin (green). The area 
enclosed by the frame is depicted in B with higher magnification. The arrow in B points to a primary 
cilium. C, 13 d old astroglial primary culture stained for Wdr16 (red) and α-tubulin (green). D, 13 d old 
astroglial primary culture stained for Wdr16 (red) and GP BB (green). Colocalisation is indicated by 
yellow colour resulting from superposition of red and green images. Scale bars: A, C, D 50 µm; B 10 
µm. Note that the plane of focus is the same in A, B and C and differs from that in D. 
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2.11. Immunohistochemistry 
 
In the next step, the Wdr16 antibody was used to investigate the expression of     
wdr16 in rat testis and rat brain by indirect immunofluorescent staining. Since 
paraffin-embedded sections failed to yield a clear signal (not shown), cryosections 
with a thickness of 10 µm were used. 
 
 
2.11.1. Staining of rat testis for Wdr16 at different animal 
age  
 
In the developing rat testis, the Wdr16 signal is absent from testicular tubules of 17 
day-old animals (Fig. 22 A). At 23 days of age, Wdr16 immunofluorescence begins to 
appear in the cytosol of early spermatocytes (Fig. 22 B). A strong wdr16 expression 
is maintained in the cytosol of early spermatocytes from day 25 to day 30, whilst the 
cytosolic signal intensity is weak in putative early spermatids at this age (Fig. 22 C, 
D). In the adult rat testis, a strong Wdr16 signal localises to pachytene 
spermatocytes, while the region of excess spermatid cytoplasm exhibits an 
ambiguous signal (Fig. 22 E). No staining can be observed in the lumen of the 
testicular tubules where the sperm flagella are located (Fig. 22 E). When the anti-
Wdr16 antibody is replaced by preimmune serum (Fig. 22 G) or is preabsorbed with 
the antigenic peptide (Fig. 22 H), the fluorescence signal disappears, demonstrating 
the specificity of the Wdr16 antibody also in immunofluorescent staining of rat testis 
cryosections. 
 
 
2.11.2. Staining of adult rat brain for Wdr16 
 
When the Wdr16 antibody preparation was applied to 10 µm cryosections of adult rat 
brain, the total ependymal layer exhibited immunoreactivity, while the brain 
parenchyma was devoid of the signal (Fig. 23). When preimmune serum was used or 
when the antibody was preabsorbed with the antigenic peptide, no specific 
fluorescence signal was detectable in the ventricular epithelium lining the ventricles 
or elsewhere.  
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Fig. 22. Immunohistochemical stainings showing the expression of wdr16 in the developing rat testis. 
Ten micrometers thin paraformaldehyde-fixed cryosections were incubated with Wdr16 antibody 
(diluted 1:200) for 30 min. The secondary antibody, donkey anti-guinea pig IgG-carbocyanin 3 
conjugate, was diluted 1:1,000 and applied for 50 min. The presence of Wdr16 is indicated by red 
fluorescence. The nuclei, counterstained with 4’,6-diamidino-2-phenylindole, appear blue. A, testis 
from 17 d old rat; B, testis from 23 d old rat; C, testis from 25 d old rat; D, testis from 30 d old rat; E, 
testis from adult rat; F, phase contrast view of E. G, Substitution of the antibody by preimmune serum; 
H, The Wdr16 antibody was preabsorbed with the antigenic peptide. Arrowheads point to early 
spermatids. Asterisks mark the lumen of the seminiferous tubule. Scale bars: 50 µm. 
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Fig. 23. Immunohistochemical stainings demonstrating reactivity and specificity for the Wdr16 
antibody in the rat brain. Ten micrometers thin paraformaldehyd-fixed cryosections of an adult rat 
brain from the area of the third ventricle were treated with Wdr16 antibody diluted 1:200 (A), Wdr16 
antibody preabsorbed with the peptide against which the antibody was raised (B), and preimmune 
serum (C), respectively. Incubation time was 30 min. The secondary antibody, donkey anti-guinea pig 
IgG-carbocyanin 3 conjugate, was diluted 1:1,000 and applied for 50 min. Asterisks mark blood-filled 
capillaries in the parenchyma exhibiting fluorescence unrelated to Wdr16. Scale bars: 50 µm. 
 
 
2.11.3. Double immunostaining of developing rat brain 
 
For immunofluorescent double stainings of developing rat brain, two consecutive 
staining protocols with in-between fixation had to be performed to avoid the loss of 
the Wdr16 signal. 
 
 
2.11.3.1. Wdr16 and α-tubulin stainings of embryonic rat brain at           
day 19 of gestation 
 
In the embryonic rat brain at day 19 of gestation, the ependyma still lacks kinocilia, as 
demonstrated here for the dorsal third ventricle immediately below the choroid plexus 
(Fig. 24 A) and for the dorsal lateral ventricle (Fig. 24 B). The presence of kinocilia 
can be taken as a differentiation marker, and the ependyma is therefore not yet 
mature in a 19 day-old rat embryo. Rather, the ventricle-lining cells are still in the 
process of proliferation, as indicated by the presence of mitotic nuclei (Fig. 24 B, 
inset). In the already further developed nasopharyngeal epithelium, however, wdr16 
is expressed in the cytosol of kinocilia-bearing epithelial cells, while it is absent from 
kinocilia-free cells (Fig. 24 C, D). 
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Fig. 24. Immunofluorescent double stainings of Wdr16 and α-tubulin in the head of embryonal rats at 
day 19 of gestation. Ten micrometers thin paraformaldehyde-fixed cryosections were incubated with 
Wdr16 antibody (1:200) and donkey anti-guinea pig IgG-carbocyanin 3 conjugate (1:1,000) to indicate 
the presence of Wdr16 (red). After an additional fixation, cilia (green) were counterstained with 
monoclonal mouse anti-α-tubulin antibody (1:1,000) in combination with goat anti-mouse IgG-Alexa 
488 conjugate (1:1,000). Incubation times were 30 min each for the first antibodies, and 50 min each 
for the secondary antibodies. Nuclei were counterstained with 4’,6-diamidino-2-phenylindole and 
appear blue. A, dorsal third ventricle, immediately below the choroid plexus; B, dorsal lateral ventricle 
with mitotic nuclei (inset); C, D, nasal respiratory epithelium. The arrow in D points to a non-ciliated 
and Wdr16-negative cell, surrounded by neighbouring kinocilia-bearing, Wdr16-positive cells. 
Asterisks mark blood-filled capillaries in the parenchyma exhibiting fluorescence unrelated to Wdr16 
(autofluorescence). Scale bars: A, B, C 50 µm; D 25 µm. 
 
 
2.11.3.2. Staining of brain from newborn rat for Wdr16 and α-tubulin  
 
In the brain of newborn rats, wdr16 expression can be observed in the ventral (Fig. 
25 A) and in the dorsal cerebral aqueduct (Fig. 25 B), where ependymal 
differentiation is evident from kinocilia projecting into the ventricles. The cerebral 
aqueduct is the region from where ependymal differentiation starts its progression 
through the ventricles in newborn animals (Banizs et al., 2005). At that 
developmental stage, the undifferentiated cells lining the ventricles are either 
unciliated or equipped with a single primary cilium, and they are also devoid of Wdr16 
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immunoreactivity (Fig. 25 C, D, E). Single cells further advanced in the differentiation 
process possess kinocilia and show a cytosolic localisation of Wdr16 (Fig. 25 F).  
 
Fig. 25. Immunofluorescent double stainings of Wdr16 and α-tubulin in the brain of newborn rat. Ten 
micrometers thin paraformaldehyde-fixed cryosections were incubated with Wdr16 antibody (1:200) 
and donkey anti-guinea pig IgG-carbocyanin 3 conjugate (1:1,000) to indicate the presence of Wdr16 
(red). After an additional fixation, cilia (green) were counterstained with monoclonal mouse anti-α-
tubulin-antibody (1:1,000) in combination with rabbit anti-mouse IgG-fluorescein isothiocyanate 
conjugate (1:2,000). Incubation times were 30 min each for the first antibodies, and 50 min each for 
the secondary antibodies. Nuclei were counterstained with 4’,6-diamidino-2-phenylindole and appear 
blue. A, ventral cerebral aqueduct; B, dorsal cerebral aqueduct; C, fourth ventricle; D, detail of C with 
primary cilia (arrows). Images A-D are from one and the same brain slice. E, third ventricle with 
Wdr16-negative cells bearing primary cilia (arrows); F, third ventricle with a single Wdr16-positive, 
kinocilia-bearing cell. Blood-filled capillaries in the parenchyma give bright fluorescence signals 
unrelated to Wdr16 (autofluorescence) and are marked by asterisks. Scale bars: A, B, C 50 µm; D, E, 
F 10 µm. 
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2.11.3.3. Costaining of Wdr16 and either α-tubulin or the brain 
isoform of glycogen phosphorylase in the brain of two 
day-old rat 
 
In the brain of two day-old rat, ependymal differentiation has reached the ventricles. 
While neither Wdr16 nor kinocilia are apparent in the ventral floor of the third ventricle 
(Fig. 26 A), the polyciliated dorsal area of the third ventricle exhibits strong Wdr16 
immunoreactivity (Fig. 26 C). The middle region of the third ventricle shows the 
transition from kinocilia-bearing to kinocilia-free ependymal cells (Fig. 26 B), which is 
accompanied by a gradient of wdr16 expression.  
 
Fig. 26. Immunofluorescent double stainings of Wdr16 and α-tubulin (A-C) or the brain isoform of 
glycogen phosphorylase (GP BB; D) in the brain of 2 day-old rat. Ten micrometers thin 
paraformaldehyde-fixed cryosections were incubated with Wdr16 antibody (1:200) and donkey anti-
guinea pig IgG-carbocyanin 3 conjugate (1:1,000) to indicate the presence of Wdr16 (red). After an 
additional fixation, cilia (green) were counterstained with monoclonal mouse anti-α-tubulin-antibody 
(1:1,000) in combination with rabbit anti mouse IgG-fluorescein isothiocyanate conjugate (1:2,000). 
The counterstaining for GP BB (green) was performed with rabbit anti-glycogen phosphorylase 
antiserum (1:1,000) in combination with goat anti-rabbit IgG-Alexa 488 conjugate (1:1,000). Incubation 
times were 30 min each for the first antibodies, and 50 min each for the secondary antibodies. Nuclei 
were counterstained with 4’,6-diamidino-2-phenylindole and appear blue. A, ventral floor of third 
ventricle; B, middle area of third ventricle; C, dorsal third ventricle. Figs. A-C were photographed from 
one and the same slide. D, colocalisation (yellow) of Wdr16 and GP BB in the area of the dorsal third 
ventricle. Blood-filled capillaries in the parenchyma give bright autofluorescence signals unrelated to 
Wdr16 and are marked by asterisks. Scale bars: A, B, C 50 µm; D 25 µm.  
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The colocalisation of Wdr16 and GP BB shown in this work in the primary culture 
system also holds true for the rat brain ependyma (Fig. 26 D). 
 
 
2.12. Zebrafish embryo as a suitable model organism 
for investigating possible Wdr16 functions 
 
A knockdown of the wdr 16 gene has the potential to identify the role of this protein in 
health and disease. A suitable model organism to study the effect of a gene 
knockdown is the zebrafish (Danio rerio). The embryos are transparent and are 
readily available due to the high number of offspring and the short generation time of 
Danio rerio, enabling a quick and easy identification of knockdown-associated 
phenotypes. An appropriate tool to generate a transient gene knockdown in zebrafish 
are the so-called ‘morpholinos’. These antisense oligomers have a morpholine 
backbone connected by phosphorodiamidates instead of phosphate-interconnected 
ribose residues (Summerton and Weller, 1997) An antisense morpholino was 
designed to hybridise to the region around the translation initiation site on the mRNA 
of the zebrafish wdr16 ortholog, preventing translation. All experiments described in 
the following were conducted in the laboratory of Hans-Martin Pogoda at the Max 
Planck Institute of Immunobiology in Freiburg, Germany. 
 
 
2.12.1. Analysis of the presence of Wdr16 mRNA in 
zebrafish embryo by in-situ hybridisation 
 
Prior to the knockdown experiments, the tissue-specific occurrence of Wdr16 mRNA 
in the zebrafish was investigated by in-situ hybridisation with DIG-labelled antisense 
RNA probe in whole-mount embryos. Representative results are depicted in Fig. 27. 
In the 10 somite embryo, Wdr16 mRNA is present in the neural tube (Fig. 27 A, B), 
the otical placodes (Fig. 27 A) and in the pronephric mesoderm (Fig. 27 B). One day-
old embryos exhibit the signal in the canal of the spinal cord, the pronephric ducts 
(Fig. 27 C), the olfactory placode, the SCO (Fig. 27 D) and in the region of the 
aqueduct between the midbrain and hindbrain (Fig. 27 C, D, E, arrow). A two day-old 
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embryo retains the Wdr16 message in the nose, the SCO (Fig. 27 F) and in the 
midbrain ventricle (Fig. 27 F, arrow). 
 
Fig. 27.  In-situ hybridisation demonstrating the presence of Wdr16 mRNA in zebrafish. In-situ 
hybridisation in the whole mount embryo was conducted with a digoxigenin-labelled antisense RNA 
probe against Wdr16 mRNA.  
A, 10 somite stage embryo, exhibiting Wdr16 mRNA signals in the neural tube (nt) and otical placode 
(otp); B, Optical cross-section of a 10 somite stage embryo revealing a signal for Wdr16 message in 
the pronephric mesoderm (pm) and in the floor of the neural tube (nt); C, 1 d old embryo showing 
Wdr16 mRNA in the canal of the spinal cord (sc), the pronephric duct (pd) and in the area of the 
aqueduct (arrow) between the midbrain and the hindbrain ventricles; D, 1 d old embryo exhibiting the 
Wdr16 message in the olfactory placode (olp), the subcommissural organ (sco) and the aqueduct 
(arrow); E, Cross-section of a 1 d old embryo displaying a pronounced signal in the aqueduct (arrow); 
F, Wdr16 mRNA is present in the nose (n), the subcommissural organ (sco) and in the midbrain 
ventricle (arrow) of a 2 d old embryo. som., somite; hpf, hours post fertilisation. 
 
 
2.12.2. Efficiency and specificity of the Wdr16 antisense 
morpholino 
 
The knockdown efficiency and specificity of the Wdr16 antisense morpholino had to 
be validated by a control experiment. For that purpose, RNA was isolated from a 1 
day-old zebrafish embryo, reverse-transcribed and subjected to a PCR reaction with 
suitable primers for the amplification of cDNA containing the part of the mRNA 
sequence against which the antisense morpholino was directed. The PCR product 
was then cloned into the MCS of the XLT.GFPTL-CS2 vector, resulting in a fusion 
construct between a part of Wdr16 and the green fluorescent protein (GFP) ORF. 
This fusion construct was coinjected into embryos at the single cell stage together 
with either the antisense morpholino (wdr16MO; Fig. 28, row C, D) or the control 
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morpholino (wdr16CoMo; Fig. 28, row A, B). In case of the negative control, green 
fluorescence is visible in the injected embryos at the mid gastrulation stage (Fig. 28 
B), while the signal is abrogated in animals treated with wdr16MO (Fig. 28 D). The 
absence of GFP expression from the embryos treated with wdr16MO, but not from 
embryos treated with wdr16CoMo, demonstrates the knockdown effectiveness and 
specificity of the antisense wdr16 morpholino employed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 28. Transfection control experiment demonstrating specific inhibition of Wdr16 mRNA translation 
by a Wdr16-directed antisense morpholino. Zebrafish embryos at the one cell stage were coinjected 
with a construct in which a part of the Danio Wdr16 antisense morpholino target sequence is fused to 
the ORF of green fluorescent protein (GFP; +wdr16-gfp) and either (A) the control morpholino 
(+wdr16CoMO) or (C) the antisense morpholino directed against the Wdr16 sequence (+wdr16MO). 
Whilst embryos treated with the control morpholio exhibit green fluorescence (B), the signal is absent 
from fish injected with the antisense morpholino (D). 
 
 
2.12.3. Consequences of Wdr16 knockdown in zebrafish 
embryos 
 
Embryos at the one cell stage were injected with either wdr16MO or with the inactive 
inverse sequence wdr16CoMo. The phenotype was inspected after 48 h post 
fertilisation (hpf). Representative examples are depicted in Fig. 29. Of 102 surviving 
embryos injected with the wdr16MO, 73 animals developed pronounced 
hydrocephalus (Fig. 29 A) and a further 19 exhibited less severe but still clear 
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hydrocephalus, while only 10 fish remained indistinguishable fom the wild type. When 
wdr16CoMo was injected, 58 out of 67 embryos did not differ in their phenotype from 
the uninjected control (Fig. 29 B), while 9 fish displayed unspecific mild retardation in 
development. Among the uninjected wild type controls, 35 out of 39 embryos 
developed normally (Fig. 29 C). The dilatation of the ventricles remained the only 
visible phenotype in Wdr16 knockdown zebrafish 48 hpf. 
 
The ependymal epithelium of the hydrocephalic zebrafish brains did not show any 
untypical morphology or disorganisation in comparison to control animals. 
Additionally, the beating of the ependymal kinocilia was unaltered compared to the 
controls as measured by high speed videography (Hirschner et al., 2007). 
 
 
 
 
 
 
 
 
 
 
Fig. 29. Phenotypes of 48 h-old zebrafish 
embryos after Wdr16 knockdown. Zebrafish 
embryos injected at the one cell stage with the 
Wdr16 antisense morpholino (+wdr16MO) 
display severe hydrocephalus (A), whilst this 
phenotype is not visible in animals injected with 
a control morpholino (+ wdr16CoMO, B) or in 
the wildtype (wt, C). hpf, hours post fertilisation. 
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2.13. Yeast-Two Hybrid Screen 
 
 WD-repeat proteins are known to mediate protein-protein interactions (Smith et al., 
1999). Therefore, a Yeast-Two Hybrid Screen was performed to find interaction 
partners of Wdr16. Since wdr16 is highly expressed in testis, the full-length Wdr16 
sequence was used as bait to screen a human testis cDNA library using the 
“Matchmaker Gal4 Two-Hybrid System 3” (purchased from Clontech), in close 
collaboration with D. Scheible, IFIB, University of Tübingen. The only identified 
candidate clone to come into question to represent a Wdr16 interaction partner 
corresponded to KIAA0179 mRNA (accession number NM_015056), the 
corresponding protein of which belongs to the Npp protein family. These proteins are 
localised in the nucleolus where they are involved in the generation of rRNA 
(http://harvester.embl.de). However, the capability of this clone to grow on selective 
medium disappeared after replating, and an ORF matching the sequence of the KIAA 
protein could not be identified. Therefore, the identified sequence turned out to be an 
artefact, which coincides with the observation that nuclear proteins are frequently 
obtained as false positives in a Yeast-Two Hybrid screen (K. Nau, F. Madeo, 
personal communication). 
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3.Discussion 
 
 
3.1. Potential of subtractive ependymal cDNA 
libraries 
 
Screening of the subtracted ependymal and SCO cDNA libraries yielded, among 
others, clones encoding Wdr16 and Spag6, indicating ependyma-specific 
transcription of these genes in the CNS. In total, 139 of the clones identified in the 
laboratory were sequenced, among which the wdr16 transcript was represented by 6 
sequences, while 10 cDNA fragments represented parts of the spag6 transcript. 
Spag6 is a constituent of the ciliary central apparatus (Sapiro et al., 2000) and can 
therefore be regarded as a marker for kinocilia. Since in the brain ependymal cells 
are the only cell type bearing kinocilia, the frequent finding of Spag6 confirms the 
high quality of the subtracted libraries and suggests them as effective tools for finding 
genes that are expressed in ependymal cells, but not elswhere in the brain 
parenchyma. 
 
 
3.2. Comparison of Wdr16 with other WD40-repeat 
proteins 
 
The predicted three-dimensional structure of the Wdr16 protein resembles the X-ray 
structure of actin-interacting protein 1 (AIP 1; Voegtli et al., 2003), a WD repeat 
protein that had been predicted by bioinformatic analysis to contain at least 10 
repeats (Ono, 2001). The architecture of AIP 1 with its two covalently linked 7-bladed 
β-propellers supports the assumption that the formation of two smaller β-propellers 
instead of only one huge propeller containing a larger number of blades seems to be 
the preferred option for proteins with more than 7 WD repeats (Voegtli et al., 2003). 
The protein involved in apoptosis, apoptotic protease activating factor-1 (Apaf-1) with 
its 12 or 13 WD repeats (Shi, 2002), also obeys this rule (Acehan et al., 2002). 
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Therefore, the predicted fold of Wdr16 into two 7-bladed β-propellers appears very 
likely. 
Despite the common motif, members of the WD-repeat protein family show a high 
degree of functional diversity, which makes it impossible to derive the physiological 
relevance of Wdr16 from its structure alone. The most prominent WD protein the 
crystal structure of which has been resolved is the β-subunit of the heterotrimeric G-
protein transducin (Wall et al., 1995; Sondek et al., 1996). Another member of the 
WD protein family that is involved in signal transduction is the receptor for activated 
C-kinase 1 (Croze et al., 2000). Other identified functions of WD repeat proteins 
aside from participation in signal transduction are reviewed in Li and Roberts (2001), 
e.g. cell cycle control (CDC20), transcriptional regulation (several TATA box-binding 
protein-associated factors), chromatin assembly (chromatin assembly factor 1), 
apoptosis (Apaf-1), motor protein complex assembly (intermediate chain 78 of 
Chlamydomonas outer dynein arm) and vesicular trafficking (α- and β-coatomer 
protein). 
 
Despite its yet unknown physiological function, Wdr16 has to be assumed to be 
engaged in protein-protein interactions, as known from other WD proteins (Smith et 
al., 1999). 
 
 
3.3. Congruence between Wdr16 and the expression 
of kinocilia 
 
Bioinformatic studies revealed Wdr16 orthologs to be restricted to organisms in 
possession of kinocilia. High evolutionary conservation of Wdr16, the occurrence in 
unicellular flagellated, as well as in kinocilia-possessing metazoic, but absence from 
flagella-lacking organisms suggests a fundamental role in cellular function connected 
to kinocilia-bearing cells. 
 
The correlation between the presence of Wdr16 and kinocilia also holds true for rat 
organs and tissues. The apparent absence of Wdr16 from lung shown by the 
Western blot experiment depicted in Fig. 9 is most readily explained by a protein level 
below the detection limit in view of the low amount of Wdr16 mRNA in lung compared 
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to EPC and testis (Table 3). Since RT-PCR also demonstrated the existence of exon 
2, wherein the antigenic sequence is located against which the antibody was raised, 
a lack of the antibody recognition site due to the occurrence of a splice variant cannot 
be the reason for the missing immunoreactivity. An attempt during the present study 
to stain rat lung and trachea with the Wdr16 antibody was unsuccessful due to an 
overwhelming background signal, probably because of the mucus contained in these 
tissues. However, wdr16 expression was demonstrated in the nasopharyngeal 
region, which is part of the upper airway epithelium. An analogous case has been 
described in Zhang et al. (2002), in which the murine ortholog of the axonemal 
protein Pf20 was detectable by immunoblotting in testis but not in the lung, although 
both tissues definitely contain kinocilia and therefore the protein. 
 
Another indication, beside bioinformatic analysis, that Wdr16 upregulation is tied to 
the presence of kinocilia or flagella is the appearance of the protein in rat testis at 
animal age of 24 days, which is also the time when the primary spermatocyte number 
per unit area of the seminiferous tubule peaks and the production of spermatids 
starts (Zhengwei et al., 1990). In the process of mammalian sperm assembly, the 
round spermatids are described to be the differentiation state, in which the formation 
of the axoneme commences (Irons and Clermont, 1982). 
 
In differentiating EPCs, the occurrence of Wdr16 protein at approximately day 7 
coincides with the beginning of kinocilia formation (S. Verleysdonk, unpublished 
data). The increase of Wdr16 protein synthesis in ageing APCs reflects an increase 
in the number of contaminating ependymal cells, a phenomenon that has already 
been observed by B. Hamprecht (personal communication, unpublished data). In the 
maturing zebrafish embryo, the message for the ortholog Wdr16 is exclusively 
present in tissues that have reached a developmental stage in which kinocilia are 
present. Kinocilia-bearing cells occur in the olfactory and otic placodes (Byrd et al., 
1996; Sumanas et al., 2003) and also in the kidney, where they are of the 9 + 2 
axonemal structure, in contrast to mammalian primary cilia in this organ (Kramer-
Zucker et al., 2005). Thus, the temporal expression pattern of Wdr16 protein in rat 
testis and in primary cell cultures, together with the observed distribution of Wdr16 
mRNA in the zebrafish, strongly implies Wdr16 as a differentiation marker for 
kinocilia-bearing cells. 
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Immunostainings localised Wdr16 to the cytosol of sperm precursor cells and to the 
cytosol of ependymal cells, while sperm tails and ependymal cilia were found to be 
free from immunofluorescence. On the other hand, Wdr16 immunoreactivity has been 
found in the tail fraction - but not in the head fraction - of fractured bull sperm by 
Western blot experiments. This allows for the possibility that the apparent lack of 
Wdr16 immunofluorescence in the immunostaining experiments on cells and tissues 
might be due to an incapacity of the Wdr16 antibody to recognise the antigen in the 
densely packed environment of the sperm axoneme. Considering that Wdr16 is a 
WD-repeat protein mediating protein-protein interactions (see above), the antigenic 
peptide stretch is very likely to be masked by an interaction partner. In view of the 
presence of a Wdr16-specific signal in the Western blot analysis of bull sperm tails, 
combined with the lack of an immunofluorescence signal in spermatozoa treated with 
the Wdr16 antiserum, it may be concluded that the peptide antibody is able to detect 
Wdr16 reliably under denaturating blot conditions, but not always in the more native 
environment present during immunostainings. This assumption is corroborated by the 
analogous absence of an α-tubulin signal in sperm tails after immunostaining with a 
monoclonal anti α-tubulin antibody (D. Scheible, personal communication). The 
presence of Wdr16 in the tail fraction does not necessarily mean that the protein is 
also present in ependymal kinocilia. The sperm tail fraction, namely, does not only 
contain the axonemal structure, but also mitochondria (Fawcett, 1975). Although 
Wdr16 was found to be predominantly cytosolic, it cannot be ruled out to be also 
present in mitochondria and it may persist in the middle section of sperm due to 
mitochondrial binding as it has been described for other cytosolic proteins like 
hexokinase (Wilson 1997), Thus, the immunoreactive signal in the Western blot 
originating from the sperm tail fraction gives no independent information about the 
subcellular localisation of Wdr16. 
 
Immunostainings not only indicate the presence of Wdr16 in kinocilia-bearing cells, 
but also its absence from non-ciliated and monociliated cells. This observation 
confirms on the cellular level what is already indicated by the correlation of wdr16 
transcription with the transcription kinetics of the kinocilia markers Spag6 and hydin 
on the one hand, but not with the general ciliary marker, polaris, on the other hand 
(Haycraft et al., 2001). Since primary cilia are known to already occur in the kinocilia-
free embryonic testis (Ward et al., 2003), the above-zero baseline of polaris mRNA in 
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this tissue (Fig. 16 K) reflects their presence in very early stages of development. The 
strong increase in testicular polaris mRNA after postnatal day 10 is based on the 
augmented demand for IFT proteins that are required for the assembly of sperm 
flagella. Therefore, the absence of Wdr16 in monociliated cells but its presence in 
polyciliated ones demonstrates that the wdr16 gene is not expressed prior to 
differentiation of the kinocilia-bearing cells in these tissues. 
 
In summary, Wdr16 can be considered as a marker protein for differentiated kinocilia-
bearing ependymal cells and thus can be used for their identification in primary 
cultures and in the brain. 
 
 
3.4. Expression of the wdr16 gene in the 
hepatocellular carcinoma cell line HepG2 
 
In a study published by Silva et al. (2005), Wdr16 mRNA is shown to be present in 
hepatocellular carcinomas and in hepatoma cell lines, but not in normal liver tissue. 
In the present study, Western blot analysis confirms the expression of Wdr16 in the 
hepatocellular tumor cell line HepG2, as well as the lack of Wdr16 in noncancerous 
liver. However, the role of Wdr16 in cell proliferation postulated by Silva et al. (2005) 
appears highly unlikely, since dividing ependymal cells are definitely devoid of Wdr16 
immunoreactivity and, beyond that, its occurrence is tied to differentiated but not to 
undifferentiated tissues. Therefore, it has to be noted that the functional pattern of 
proteins in highly dedifferentiated cancer cells does not necessarily reflect their 
functions under physiological conditions.  
 
 
3.5.Colocalisation of Wdr16 and the brain isoform of 
glycogen phosphorylase 
 
Wdr16 is shown to colocalise with GP BB. The glycogen present in ependymal cells 
(Cataldo and Broadwell, 1986; Prothmann et al., 2001) is thought to serve as an 
internal energy store that is degraded by GP BB in response to an increased cellular 
energy demand. For example, the neurotransmitters serotonin and noradrenaline 
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cause an increase in ependymal ciliary beat frequency and simultaneously in 
glycogenolysis (Nguyen et al., 2001; Prothmann et al., 2001; Verleysdonk et al., 
2005). Beyond that, ependymal cells seem to be involved in water homeostasis of the 
brain, a process that requires active, ATP-driven ion transport (see Introduction and 
Brown et al., 2004). These active ion transport processes, putatively elicited by NPs 
that are known to evoke a response in ependymal cells (Wellard et al., 2003; 2006) 
might be another cause for glycogen-fueled energy consumption. 
 
 
3.6. Comparison of Wdr16 knockdown-associated 
hydrocephalus with other animal models of 
hydrocephalus 
 
The knockdown of Wdr16 in zebrafish results in the formation of severe 
hydrocephalus, while ciliary motility and ependymal morphology are unaltered with 
respect to the control animals and the wild type. 
 
This is in contrast to several animal models linking the formation of hydrocephalus to 
defunct cilia. For example, mice with a mutated gene encoding dynein heavy chain 
Mdnah5 are characterised by a reduced number of outer dynein arms in the 
axoneme of ependymal cilia, which leads to impaired ciliary beating. This in turn 
abrogates the directed CSF flow through the aqueduct of Sylvius resulting in 
aqueductal stenosis with dilated lateral and third ventricles (Ibanez-Tallon et al., 
2002; 2004). While Mdnah5-/- mice always suffer from enlarged ventricles, human 
beings bearing mutations in the orthologous gene dnah5 incur only an 80 times 
higher risk of developing aqueductal stenosis compared to the average of the 
population (Ibanez-Tallon et al., 2004). The clinical symptoms of primary ciliary 
dyskinesia (PCD; OMIM 244400) are a 50 % chance of situs inversus (randomisation 
of body left-right axis), chronic respiratory infections and immotile sperm due to 
defunct cilia and flagella. Hydrocephalus, however, is not commonly associated with 
this disease (Afzelius and Mossberg, 1995). Therefore, ciliary immotility need not 
necessarily result in the formation of ventriculomegaly, as evident from mice deficient 
in Spag6, a protein that localises to the central apparatus of the axoneme (Sapiro et 
al., 2000; 2002). While Spag6-/- mice show ultrastructural defects in and impaired 
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motility of the sperm axoneme, only 50 % of these animals are affected by 
hydrocephalus (Sapiro et al., 2002). The fact that defects in ciliary motility alone are 
not the decisive factor for the development of hydrocephalus is further evident from 
mice harbouring a defect in the gene tg737. This gene encodes  polaris, a constituent 
of the IFT machinery (Haycraft et al., 2001). The IFT complex is required for the 
assembly and the maintenance of cilia (Rosenbaum and Witman, 2002). Tg737orpk 
mice, in fact, have disorganised ependymal cilia and display impaired ciliary beating 
in combination with reduced fluid flow along the ependymal cell surface, but the 
onset of hydrocephalus in these animals has been reported to precede cilia formation 
(Banizs et al., 2005). These authors postulated that hydrocephalus in tg737orpk 
mutants forms because of altered ion fluxes. A disturbance in brain water 
homeostasis and osmoregulation has also been suggested for mutant hy3 mice 
which, besides hydrocephalus, also develop brain edema (McLone et al., 1971; 
1973). The transcription profile of the underlying hydin gene is similar to the one 
established for wdr16 in the present study. The eventual loss of cilia and disruption of 
the ependymal layer seen in hy3 mice with full-blown hydrocephalus is regarded as a 
secondary effect (Bannister and Chapman, 1980). The hydrocephaly with hop gait 
(hyh) mouse strain bears a defect in the gene encoding α-SNAP (Hong et al., 2004), 
a protein with a crucial role in membrane trafficking. The consequence of α-SNAP 
malfunction is a mislocalisation of apical proteins like E-cadherin, β-catenin, atypical 
protein kinase C and the soluble NSF attachment protein receptor (SNARE) Vamp7 
(Bajjalieh, 2004; Chae et al., 2004). These observations in the hyh mouse strain 
clearly link cell polarity defects to hydrocephalus. Furthermore, the lack of the 
transmembrane domain of the cellular adhesion molecule L1CAM, resulting from a 
frameshift mutation, prevents its proper localisation and causes hereditary X-linked 
hydrocephalus (Takahashi et al., 1997). A defect in cell polarity might also be the 
cause for the ventriculomegaly observed in Wdr16-deficient zebrafish embryos, as 
disussed in 3.8.  
 
The denudation of the ependyma and the malformation of cilia have been described 
as consequences or secondary effects, rather than causes, of hydrocephalus. Since 
the zebrafish Wdr16 knockdown phenotype occurs in a very early developmental 
stage, namely embryonal day two, it can not be excluded that such secondary effects 
would manifest in older animals. The period of time, however, during which zebrafish 
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morphant phenotypes can be characterised is limited to early stages. The amount of 
antisense morpholino per cell is halved with each cell division. In consequence its 
gene-silencing effect and the associated phenotype will disappear during 
adolescence, a period of massive cell proliferation. 
 
 
3.7. Impact of cilia on the generation of cell polarity 
and intracellular signalling 
 
As apparent from the animal models mentioned above, one important primary 
mechanism of  pathogenesis for hydrocephalus seems to involve the perturbance of 
cell polarity. Epithelial cells, and by this token also ependymal cells, posses an apical 
and a basolateral region. Moreover, they can be polarised within the plane 
perpendicular to the apical-basal cell axis (Drubin and Nelson, 1996; Shulman and 
St. Johnston, 2000). This phenomenom, described as planar cell polarity (PCP), is 
orchestrated by the Wnt/PCP pathway, also known as noncanonical Wnt pathway 
(Katoh, 2005). In contrast to the canonical (classical) Wnt signalling pathway 
involving glycogen synthase kinase 3β and β-catenin, the PCP pathway results in the 
activation of RhoA, c-Jun N-terminal kinase (JNK) and NF-kappaB essential 
modulator-like kinase (Katho, 2005). A core signalling molecule of the PCP pathway 
in Drosophila is van Gogh/strabismus, a four-pass transmembrane protein that plays 
a key role in organising wing hair and ommatidium polarity (Taylor et al., 1998; Wolff 
and Rubin, 1998). On the molecular level, van Gogh/strabismus is discussed to 
repress the canonical Wnt/β-catenin pathway and to activate JNK (Park and Moon, 
2002). Defects in the van Gogh/strabismus mammalian ortholog vangl2 lead to 
mispolarised hair cells in the inner ear (Montcouquiol et al., 2003). Loop tail mice 
(Strong and Hollander, 1949) bearing mutations in vangl2 (also termed Ltap) suffer 
from an open neural tube, a defect termed craniorachischisis (Kibar et al., 2001; 
Murdoch et al., 2001). Ross et al. (2005) described these phenotypes also for mice 
bearing mutations in genes that are associated with the inheritable disease known as 
Bardet-Biedl syndrome (BBS; OMIM 209900). Eleven BBS genes have been 
identified to date (Blacque and Leroux, 2006) and their corresponding proteins are 
localised to ciliary structures like the axoneme and the basal body (Beales, 2005). 
Thus, BBS is linked to defects affecting the assembly or function of cilia and basal 
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bodies (Ansley et al., 2003; Li et al., 2004). BBS genes are known to genetically 
interact with the PCP gene vangl2 in mice and zebrafish (Ross et al., 2005). Since 
the vangl2 protein is localised to the basal body and along the axoneme (Ross et al., 
2005), its expression is reminiscent of that of the BBS proteins. This indicates that 
cilia are intrinsically involved in PCP processes, demonstrating a function for these 
organelles independent from generating motility and fluid flow. Similar to van 
Gogh/strabismus, the protein inversin that is located to cilia and basal bodies has 
been shown to turn off the classical Wnt/β-catenin pathway, and it appears to direct 
signalling towards the noncanonical route (Simons et al., 2005). These 
considerations allow for a connection to be made between (kino)cilia and cell polarity, 
offering an explanation for the involvement of cilia in the pathogenesis of 
hydrocephalus independent from their motility. Defects in cell polarity might 
conceivably lead to mislocalisation of proteins critical for water homeostasis and 
osmoregulation (see 3.8). 
 
 
3.8. Putative function of Wdr16 
 
While sensing, signalling, as well as the generation and maintenance of cell polarity 
have been linked to primary immotile cilia with a 9+0 architecture rather than to 
motile 9+2 kinocilia, this sharp distinction appears to be unjustified. 
 
The embryonal node, a triangular indentation in developing mammals, protrudes cilia 
with the 9+0 architecture that are endowed with dynein arms (Takeda et al., 1999) 
and propel a leftward fluid flow required for the left-right pattering of the body axis 
(Nonaka et al., 1998). On the other hand, dynein arm-lacking olfactory cilia, which are 
equipped with receptors for perceiving odours show a 9+2 axonemal structure 
(Afzelius, 2004), making them an example for 9+2 cilia involved in environment 
sensing and transmitting signals. Apart from that, sensory 9+2 cilia exist on vestibular 
hair cells (Ibanez-Tallon et al., 2003), and they have been shown to be motile (Flock 
et al., 1977). However, sensory 9+2 kinocilia must be regarded as the exception and 
not as the standard. 
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All extant flagella and cilia, regardless of their axonemal organisation, are 
evolutionary derived from a precursor featuring the 9+2 axonemal architecture 
(Mitchell, 2004). During evolution from flagellated, free-living genera to kinocilia-
bearing cells within highly organised metazoan organisms, the function of the 
organelle presumably has changed substantially. The role in generating locomotive 
force has apparently become uncoupled from the ciliary capability to organise the cell 
and to generate its polarity. This hypothesis might explain why hydin knockdown 
morphants of bloodstream trypanosoma show motility defects (Broadhead et al., 
2006), while no impaired ependymal cilia beating has been described for hydin 
mutant mice (Davy and Robinson, 2003). A presumed decoupling of ciliary 
locomotive and cell-organising functions is likely to have two evolutionary 
consequences. The first one is the loss of motility-generating constituents in 
stationary metazoan cells, resulting in central apparatus- and outer dynein arm-
deficient primary cilia (Afzelius, 2004). Secondly, there may be a functional and/or 
spatial rearrangement of former motility-associated ciliary proteins. For instance, an 
ion channel previously required for Ca2+ entry into the ciliary compartment in 
connection with axonemal movement (Machemer and Ogura, 1979) might have 
evolved into a sensor involved in cellular signalling. It is also plausible that such 
channels became localised to the plasma membrane during the process of 
restructuring the axoneme, where they evolved into ion channels or transporters that 
now play a crucial role in secretion, osmoregulation and fluid homeostasis. In both 
cases, the channels or transporters have to reach their proper target, and proteins 
like Hydin and Wdr16 may be hypothesised to be involved in directing them to the 
correct cellular domain. During evolution, former Hydin and Wdr16 interaction 
partners may have changed function and/or subcellular location, but could still 
depend on Hydin and Wdr16 to guarantee their proper cellular targeting and 
therefore the polarisation of the cells. This situation resembles the one reported for 
the vesicular trafficing protein α-SNAP, which is required for targeting various 
proteins in the cell (Bajjalieh, 2004; Chae et al., 2004).  
 
In summary, the most likely function of Wdr16 is that of an adapter protein 
contributing to the proper polarisation of the cell by targeting ion channels and 
transporters to their correct destination. 
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3.9. Outlook and perspectives 
 
The present work has shown Wdr16 to be tied to the formation of kinocilia, and a 
gene knockdown by antisense morpholinos resulted in the formation of severe 
hydrocephalus in the zebrafish without altered ependymal morphology or ciliary beat. 
These knockdown effects should be further validated by additional morpholinos that, 
for instance, block the correct splicing of Wdr16 pre-mRNA. A rescue experiment in 
which the full length Wdr16 mRNA coinjected with wdr16MO should restore the wild 
type phenotype would be another desirable experiment to confirm the reliability of the 
wdr16 knockdown phenotype. 
 
Wdr16 knockdown studies by the RNAi technique with EPCs as the model would be 
an effective instrument to analyse the late effects of Wdr16 silencing that could not 
be accessed in the zebrafish model. 
 
In order to gain a deeper insight into the molecular function of Wdr16, it would be 
desirable to identify its interaction partners. Since a Yeast-Two Hybrid screen using 
Wdr16 as a bait failed, coimmunoprecipitation or tandem affinity purification should 
be tried.  
 
Additionaly, Wdr16 knockout mice would be a powerful system to study further the 
pathological defects associated with Wdr16 malfunction. 
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4. Materials and methods 
 
4.1. Materials 
 
4.1.1. Devices 
 
Autoclave    Type 669, Aigner, München 
Cameras    Coolpix 995, Nikon, Düsseldorf 
     Canon EOS 350D, Canon, Krefeld 
     Lumenera Lu 170 high-speed, Lumenera, via 
     Framos, München 
Cell incubator   Type B 5060 EC CO2, Heraeus, Hanau 
Centrifuge    Heraeus/Christ Varifuge K, Heraeus, Hanau 
Containment hood   Lamin Air HLB 2448, TL 2448, Heraeus, Hanau 
Cryostat    HM 505 E, Microm, Volketswil, Switzerland 
Cryosystem    Chronos 80 and N2-tank Jupiter,  
     Siegtal Cryotherm, Siegen 
Drying furnace   Typ U-30, Memmert, Schwabach 
Electroblotting chamber  Bio-Rad, München 
Electrophoresis chamber  for agarose gels: Model B1 (110x90mm), 
     Owl separation systems, USA 
     for polyacrylamide gels: Bio-Rad, München 
ELISA reader Titertec Plus MS 212, Friedrich S.  Bartolomey 
Labortechnik, Alfter; connected to a  personal 
computer (PC), running EIA3 software by ICN,  
     Meckenheim  
Gel documentation system Mitsubishi, Japan 
Heating block   Grant QBT, CLF Laborgeräte, Emersacker  
Hybridisation oven   Biometra, Göttingen 
LightCycler     Roche, Mannheim 
Magnetic stirrer    IKAMAG RCT, Bachofer, Reutlingen 
Microscopes    Model IM 35 and Axiovision 2, Zeiss, 
     Oberkochen 
Microwave oven   Micro-Chef FM 3915 Q, Moulinex,  
     Kaufland, Tübingen 
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Osmometer    Osmometer Automatic, Knauer, Eppelheim 
PCR Thermocycler   Primus 96 plus, MWG AG Biotech, Ebersberg 
pH-meter    PHM 92, Radiometer, Copenhagen, Denmark 
Pipettors    Finn pipettors (5-40 µl, 40-200 µl, 200-1000 µl), 
     Labsystems, Finland 
     Eppendorf pipettors (0.5-10 µl, 10-100 µl, 
     200-1000 µl), Eppendorf, Hamburg 
     Multichannel pipettor Titerman, Eppendorf, 
     Hamburg 
Power supply   Consort E 132, BioBlock Scientific, Illkirch, France 
     2301 Macrodrive 1, LKB Bromma, Vienna, Austria 
     Power Supply Model 200, Bethesda Research 
     Laboratories, Life Technologies, Inc., USA 
     Computer Controlled Electrophoresis Power Supply 
     Model 3000 X, Bio Rad, München 
Scales    Typ 1403, L2205 and 1712, Sartorius, Göttingen 
SDS PAGE device   Ready Gel Cell, Bio-Rad, München 
Shaker    Vortex Genie, Bender & Hobein, München 
Shaking platform   Horizontal-Schüttelplattform KL2, Bühler, Tübingen
     Inkubator, Wilhelm Störk, Klingenberg 
Sonifier    Branson B-30 with microtip, Heinemann, 
     Schwäbisch Gmünd 
Spectrophotometers  Shimadzu UV-120-01, Kyoto, Japan 
     Uvikon 860 with Plotter 800, Kontron, Eching 
Table top centrifuge  Centrifuge 5415 C, Eppendorf, Hamburg 
Tissue homogeniser  Potter-Elvehjem homogeniser, Braun, Melsungen 
Vacuum filter device  Sterilfiltrationsapparatur, Millipore, Eschborn 
Water bath    Julabo Standard, Julabo PC Thermostat, Labora, 
     Mannheim 
Water conditioning unit  USF Elga (0.22 µm-filter), Purelabs, USA 
Welding apparatus   Super Poly 281, Audion Elektron, Kleve 
X-ray film developing machine Röntgenfilm-Entwicklungsmaschine  
     SRX-101, Konica Europe, Hohenbrunn 
X-ray film exposure cassette Hypercassette, Amersham Buchler, Braunschweig 
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4.1.2. General material       
 
Coverslips (24 mm x 60 mm)   Roth, Karlsruhe 
Coverslips (18 mm x 18 mm)   Roth, Karlsruhe 
Cryotubes 5 ml, sterile    Greiner, Frickenhausen  
Culture dishes (35 mm x 10 mm), sterile Becton Dickinson, Heidelberg 
Culture flasks 80 cm2, sterile    Nunc, Wiesbaden 
Filter paper (Whatman 3MM)   Whatman, Göttingen 
Filtration units (Millex units), sterile  Millipore, Eschborn 
Glass pipettes 1 ml, 5 ml, 10 ml   Hirschmann, Eberstadt 
Glassware      Schott, Mainz; Brand, Wertheim 
Hybridisation container    Fisher Scientific, Schwerte 
Microscope slides (26 mm x 76 mm x 1 mm) Menzel, via Roth, Karlsruhe 
Microscope slides “Superfrost” 
(26 mm x 76 mm x 1 mm)    Menzel, via Roth, Karlsruhe 
Microtiter plates (Immunoplate F96)  Nunc, Wiesbaden 
Nitrocellulose membrane      
(Trans-Blot, 0.45 µm)    Bio-Rad, München 
Nylon cloth (132, 210 µm mesh size)  Sefar GmbH, Wasserburg/Inn 
Nylon membrane, positively charged  QBIOgene, Heidelberg 
PCR tubes (0.2 ml), sterile   PeqLab, Erlangen 
Petri dishes (AD94/H16 mm), sterile  Roth, Karlsruhe 
Pipette tips      Braun, Melsungen 
Plastic tubes 14 ml, sterile    Greiner, Frickenhausen  
Plastic tubes 50 ml, sterile    Nunc, Wiesbaden 
Plastic reaction tubes 1.5 ml   Brand, Wertheim 
X-ray film      Amersham, Freiburg 
 
 
4.1.3. Chemicals 
 
Ammonium peroxodisulfate (APS)  Fluka, Steinheim 
Bradford assay dye reagent   Bio-Rad, München 
Bromophenol blue     Fluka, Steinheim 
BSA       Sigma-Aldrich, Steinheim 
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”CDP-Star”  chemiluminescence 
substrate      Roche, Mannheim 
Coomassie Brilliant Blue R 250   Sigma-Aldrich, Steinheim 
D-Glucose      Fluka, Steinheim 
Dimethylsulfoxide (DMSO)   Sigma-Aldrich, Steinheim 
EDTA       Roth, Karlsruhe 
Glycerol      Roth, Karlsruhe 
Glycine      Roth, Karlsruhe 
Isopentane      Fluka, Steinheim 
JetPEITM transfection reagent   QBIOgene, Heidelberg 
Mercaptoethanol     Roth, Karlsruhe 
MnCl2       Fluka, Steinheim 
3-(N-Morpholino) propanesulfonic acid       
(MOPS)      Fluka, Steinheim 
NaCl       Roth, Karlsruhe 
NaHCO3       Roth, Karlsruhe 
Neg 50 cryomedium    Richard-Allan Scientific, 
       Kalamazoo, MI, USA 
PageRulerTM prestained protein ladder  MBI Fermentas, St. Leon-Rot 
Paraformaldehyde (PFA)    Fluka, Steinheim 
p-Nitrophenylphosphate    Roche, Mannheim 
Ponceau S       Serva, Heidelberg 
RbCl2       Sigma-Aldrich, Steinheim  
Roti-Block 10-fold Concentrate   Roth, Karlsruhe 
Roti-ImmunoBlock 10-fold Concentrate Roth, Karlsruhe 
Rotiphorese Gel 30    Roth, Karlsruhe 
SDS       Fluka, Steinheim 
Sucrose      Roth, Karlsruhe 
N,N,N’,N’-Tetramethylethylenediamine      
(TEMED)      Sigma-Aldrich, Steinheim 
Tissue Tek O.C.T compound    Sakkura Finetek, Zoeterwoude,  
       the Netherlands 
Trichloroacetic acid     Fluka, Steinheim 
Tris(hydroxymethyl)aminomethane (Tris) Roth, Karlsruhe 
Tween 20      Fluka, Steinheim 
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Vectashield mounting medium     
with 4’,6-diamidino-2-phenylindole  
(DAPI; 1.5 µg/ml)     Vector, via Alexis (Axxora), Grünberg
    
All other chemicals were purchased from E. Merck, Darmstadt 
 
 
4.1.4. Kits 
 
Advantage 2 PCR kit   Clontech (now Takara Bio), Heidelberg 
Enhanced chemiluminescence (ECL) 
detection reagent    Amersham, Freiburg  
FastStart DNA Master    
SYBR Green I kit    Roche, Mannheim 
High Fidelity PCR Enzyme Mix  MBI Fermentas, St. Leon-Rot 
HotStarTaq Master Mix   Qiagen, Hilden 
Imject Conjugation kit   Pierce, via PerbioScience, Bonn 
Omniscript reverse transcriptase kit Qiagen, Hilden 
PCR digoxigenin (DIG) probe 
synthesis kit     Roche, Mannheim 
PCR SelectTM cDNA subtraction kit Clontech (now Takara Bio), Heidelberg 
PCR-Select differential screening kit Clontech (now Takara Bio), Heidelberg 
QIAGEN PCR Cloningplus kit  Qiagen, Hilden 
QIAprep spin miniprep kit   Qiagen, Hilden 
QIAquick gel extraction kit   Qiagen, Hilden 
QIAquick PCR purification kit  Qiagen, Hilden 
RNeasy RNA isolation kit   Qiagen, Hilden 
SAWADY Pwo DNA Polymerase kit PeqLab, Erlangen 
SMARTTM PCR cDNA synthesis kit Clontech (now Takara Bio), Heidelberg 
SulfoLink Coupling gel   Pierce via PerbioScience, Bonn 
T4 ligation kit    MBI Fermentas, St. Leon-Rot 
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4.1.5. Reagents for molecular biology 
 
Agarose      PeqLab, Erlangen 
Anti-DIG-alkaline phosphatase (AP), 
Fab fragments     Roche, Penzberg 
dATP, dCTP, dGTP, dTTP (10 µM each) Promega, Mannheim 
Deoxyribonucleoside triphosphate (dNTP; 
(10 mM each)     PeqLab, Erlangen 
Dithiothreitol (DTT), 0.1 M    Gibco BRL, Karlsruhe 
DNA size standards     
(peqGold 100 bp Plus DNA ladder,      
1kb plus DNA ladder)    PeqLab, Erlangen   
     
Ethidium bromide     Fluka, Steinheim 
Oligo(dT15) adapter primer   Invitrogen, Karlsruhe 
PANScript NH4 buffer    PAN Biotech, Aidenbach 
PCR primers      Invitrogen, Karlsruhe 
Phenol/chloroform/isoamyl alcohol    
(25 : 24 : 1)      Applichem, Darmstadt 
Random hexamer primer (500 µg/ml)  Promega, Mannheim 
RNAsin ribonuclease inhibitor (40 U/µl)  Promega, Mannheim 
 
 
4.1.6. Enzymes for molecular biology 
 
Avian myeloblastosis virus (AMV) 
reverse transcriptase (20 U/µl)  PeqLab, Erlangen 
Calf intestine alkaline phosphatase  
(CIAP; 70 U/µl)    Invitrogen, Karlsruhe 
BamHI     New England Biolabs, Frankfurt a.M. 
EcoRI      New England Biolabs, Frankfurt a.M. 
EcoRV     New England Biolabs, Frankfurt a.M. 
HindIII     New England Biolabs, Frankfurt a.M. 
PvuII      MBI Fermentas, St. Leon-Rot 
XhoI      New England Biolabs, Frankfurt a.M. 
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4.1.7. Constituents and reagents for bacterial and 
mammalian cell culture media 
 
Antimycotic      Sigma-Aldrich, Steinheim 
Carbenicillin, disodium salt   Roth, Karlsruhe 
Dulbecco’s modified Eagle’s medium  
(DMEM), powder lacking pyruvate 
and NaHCO3      GibcoBRL, Karlsruhe   
Fetal calf serum (FCS)    Biochrome, Berlin 
Hank’s balanced salt solution (HBSS)  GibcoBRL, Karlsruhe 
Insulin      Sigma-Aldrich, Steinheim 
Kanamycin      Applichem, Darmstadt 
LB (lysogeny broth) agar powder   Fluka, Steinheim 
LB powder      Fluka, Steinheim 
Minimal Essential Medium (MEM) powder GibcoBRL, Karlsruhe 
Penicillin G, potassium salt   Serva, Heidelberg 
Super optimal broth, catabolite repression 
(SOC) medium     Novagen, Schwalbach/Ts. 
Streptomycin sulfate    Serva, Heidelberg 
Thrombin (human)     provided by M. Rapp,  
       ZLB Behring, Marburg 
Transferrin      Roche, Mannheim 
Trypsin      ICN, Eschwege    
 
 
4.1.8. Antigenic peptide 
 
CQAINTNEQNFLHGHGN   synthesized by K.-H. Wiesmüller,  
Interfaculty Institute for Biochemistry (IFIB), 
      University of Tübingen 
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4.1.9. Antibodies 
 
4.1.9.1. Primary antibodies     
 
Monoclonal anti-α-tubulin ascites fluid  Sigma-Aldrich, Steinheim 
Rabbit antiserum against GP BB   gift from B. Pfeiffer-Guglielmi, 
       IFIB, University of Tübingen 
 
 
4.1.9.2. Secondary antibodies 
 
Donkey anti-guinea pig IgG-carbocyanin 3 
(Cy3) conjugate      Jackson, via Dianova, Hamburg 
Donkey anti-guinea pig IgG-peroxidase conjugate Jackson, via Dianova, Hamburg 
Goat anti-guinea pig IgG-Alexa 546 conjugate  Molecular Probes, via 
        Invitrogen, Karlsruhe 
Goat anti-mouse IgG-Alexa 488 conjugate  Molecular Probes, via  
        Invitrogen, Karlsruhe 
Goat anti-guinea pig IgG-AP conjugate   Jackson, via Dianova, Hamburg 
Goat anti-rabbit IgG-Alexa 488 conjugate  Molecular Probes, via 
        Invitrogen, Karlsruhe 
Rabbit anti-mouse IgG-fluorescein isothiocyanate  
(FITC) conjugate      Jackson, via Dianova, Hamburg 
 
 
4.1.10. Bacterial strains 
 
DH5α E. coli cells      gift from F. Madeo, IFIB, 
        University of Tübingen 
NovaBlue SinglesTM competent cells   Novagen, Schwalbach/Ts. 
Qiagen EZ competent cells    Qiagen, Hilden 
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4.1.11. Mammalian cells 
 
A9 fibroblasts (mouse)   provided by B. Hamprecht, 
      IFIB, University of Tübingen 
HepG2 cells  American Type Culture Collection (ATCC; 
catalog number HB-8065), via Promochem, 
Wesel 
 
 
4.1.12. Animals 
 
Wistar rats    purchased from Charles River, Kisslegg, 
     bred in the animal facility of the institute 
 
 
4.1.13. Vectors 
 
pDrive cloning vector, Qiagen, Hilden 
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pEGFP-N1 vector, Clontech (now Takara Bio), Heidelberg 
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pDNR-1r vector, Clontech (now Takara Bio), Heidelberg 
 
 
 
 
4.2. Methods 
 
4.2.1. Cell culture techniques 
 
4.2.1.1. Media and solutions for cell cultivation 
 
Penicillin/streptomycin (PS) stock solution 
651 mg penicillin G potassium salt (1536 U/mg) and 1 g streptomycin sulfate (750 
U/mg) dissolved in 50 ml ddH2O 
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Puck’s D1 solution 
137 mM NaCl, 5.4 mM KCl, 0.22 mM KH2PO4, 0.17 mM Na2HPO4; pH 7.4 
 
Puck’s D1 / Gluc / Suc solution 
5 mM D-glucose, 58.4 mM sucrose in Puck`s D1 solution 
 
Trypsin solution 0.05 % (w/v) 
Puck’s D1 / Gluc / Suc solution supplemented with 0.2 % (v/v) phenol red and  
0.05 % (w/v) trypsin 
 
MEMWash 
9.65 g MEM powder and 2.2 g NaHCO3, dissolved in 1 L ddH2O. The medium was 
gassed with CO2 until the colour became orange. 
 
MEMC 
MEMwash  medium supplemented with 0.5 g/L BSA, 5 mg/L insulin, 10 mg/L 
transferrin and 1 mL PS stock solution per liter of medium 
 
MEMCT 
MEMC supplemented with 500 U/L thrombin 
 
DMEM 
133.75 g DMEM powder lacking pyruvate and NaHCO3, 2.2 g sodium pyruvate and 
74 g NaHCO3 were dissolved in 20 L ddH2O. The medium was gassed with CO2 until 
the colour became orange. The osmolarity was 320-340 mOsmol/L. 
 
90 % DMEM / 10 % FCS 
900 mL DMEM plus 100 mL FCS  
 
90 % DMEM / 10 % FCS / PS 
1 mL PS stock solution was added to 1 L 90 % DMEM / 10 % FCS 
 
90 % DMEM / 10 % FCS / antimycotic 
1 mL 1000-fold concentrated antimycotic stock solution was added to 1 L 90 % 
DMEM / 10 % FCS 
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4.2.1.2.Ependymal primary cultures 
 
EPCs were prepared from brains of newborn Wistar rats not older than 24 h 
according to the method of Weibel et al. (1990) as modified by Prothmann et al. 
(2001).  
 
Coating of culture dishes with fibronectin 
Fibronectin was isolated according to Miekka et al. (1982) with modifications 
described by Prothmann (1995). 
Culture dishes 35 mm in diameter were incubated with 0.7 mL of sterile-filtered 
fibronectin solution (200 µg/mL) at 37°C for 2 h. Afterwards, fibronectin was sucked 
off and replaced by 2 mL MEMwash. Coated culture dishes were stored in a cell 
incubator at 37°C in an atmosphere of 95 % air and 5 % CO2 until cells were seeded. 
 
Preparation of rat brains 
Newborn rats were decapitated with a pair of scissors. The brains were squeezed 
through the foramen magnum by application of pressure to the skull roof and 
transferred to a Petri dish containing 10 mL ice-cold Puck`s D1 / Gluc / Suc solution. 
 
Dissociation into single cells 
Prior to the procedure, nylon cloth (132 µm and 210 µm mesh size) was sealed with 
a welding apparatus to obtain nylon gauze bags. The brains were packed into a 210 
µm mesh size nylon gauze bag and dissociated by massaging them through the 
mesh with sterile forceps. The suspension was collected in a Petri dish filled with 10 
mL ice cold Puck’s D1 / Gluc / Suc solution, where it was triturated to apparent 
homogeneity with a 10 mL glass pipette. For removal of remaining large aggregates, 
the cell suspension was filtered through a 132 µm mesh size gauze bag into a 50 mL 
plastic tube. After 5 min of centrifugation in a Heraeus/Christ Varifuge K at 1500 
revolutions per minute (rpm) and 4°C, the supernatant was sucked off and the pellet 
was resuspended in 10 mL of MEMc. The suspension was passed through a 132 µm 
mesh size gauze bag into an appropriate volume of MEMC to yield the seeding 
suspension. For each dissociated brain, 30 mL of MEMC were used.  
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Seeding of dissociated brain cells 
MEMwash was removed from fibronectin-coated dishes and replaced by 2 mL cell 
suspension in MEMC. Seeded cells were cultivated at 37°C in an atmosphere of 95 % 
air and 5 % CO2. After 2 days, MEMC was replaced by MEMCT. The culture medium 
was renewed every 2 or 3 days until the cultures were used for experiments. The 
state of the cultures was permanently monitored under a microscope. 
 
 
4.2.1.3. Astroglial primary cultures 
 
APCs were prepared from the brains of newborn Wistar rats following the procedure 
of Hamprecht and Löffler (1985) with the modifications described below. The animals 
were used at a maximal age of 36 h. 
 
Dissociation into single cells 
This procedure was conducted as described in 4.2.1.2. with the following 
modifications: 
After centrifugation, the pellet was resuspended in 90 % DMEM / 10 % FCS / PS. For 
each brain, 50 mL of medium were used. 
 
Seeding of the cells   
The cell suspension was transferred to culture dishes 35 mm in diameter. Seeded 
cells were cultivated at 37°C in an atmosphere of 90 % air and 10 % CO2. The 
medium was routinely renewed on culture day 7 and from thereon each seventh day. 
The state of the cultures was regulary monitored under a microscope.  
Nearly homogeneous astroglial cultures (provided by R. Schmid, IFIB, University of 
Tübingen) were derived from APCs by replacing the standard medium with 90 % 
DMEM / 10 % FCS lacking all amino acids except serine, glutamine and glycine at 
culture day 5 (Verleysdonk, 1994). 
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4.2.1.4. Cultures of the mouse fibroblast cell line A9 
 
Starting of the culture 
The A9 fibroblast cell line (Littlefield, 1966) was provided by B. Hamprecht as a 
cryostock at passage number 36. The cryostock was thawed rapidly at 37°C. 
Afterwards, the cell suspension was transferred to an 80 cm2 culture flask containing 
20 mL 90 % DMEM / 10 % FCS / PS which was subsequently incubated at 37°C in 
an atmosphere containing 10 % CO2 (in air) for 4 h. After that time the cells were 
attached to the culture dish and the medium was renewed by fresh 90 % DMEM / 10 
% FCS / PS.  
 
Maintenance of the cell culture 
The A9 fibroblast cell line was cultured in 80 cm2 culture dishes using 90 % DMEM / 
10 % FCS / PS at 37°C in an atmosphere containing 10 % CO2 (in air). The medium 
was renewed every third day. The state of the cultures was regulary monitored under 
a microscope. 
 
Passaging of the cells 
When the cells became confluent in the 80 cm2 flask (after approximately 8-10 days), 
the culture medium was sucked off and the adherent cells were washed with 1 mL  
trypsin solution (0.05 %, w/v). Subsequently, the washing solution was discarded, 
replaced by 2 mL trypsin solution (0.05 %, w/v) and the flask was incubated at 37°C 
in a cell incubator until the cells started to detach (after approximately 5 min). To 
inhibit trypsin activity, 10 mL of 90 % DMEM / 10 % FCS / PS were added to the 
detached fibroblasts and the suspension subsequently transferred to a 50 mL plastic 
tube. After centrifugation (1500 rpm, 4°C, 5 min) in a Heraeus/Christ Varifuge K, the 
supernatant was discarded and the cell pellet was triturated with 20 mL  90 % DMEM 
/ 10 % FCS / PS. To start a new passage, 500 µL of this cell suspension were added 
to a new culture flask containing 10 mL 90 % DMEM / 10 % FCS / PS. 
 
Preparation of cryostocks 
For the preparation of cryostocks, a DMSO cell-freezing solution was prepared 
containing 2.9 mL 90 % DMEM / 10 % FCS / PS and 0.7 mL DMSO per cryosample. 
The solution was kept on ice until further use. The cells were trypsinised as described 
above and resuspended in 10 mL culture medium (90 % DMEM / 10 % FCS / PS) 
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after centrifugation. Two milliliters of the cell suspension were transferred to a 5 mL 
cryovial followed by the addition of 2.4 mL precooled DMSO cell-freezing solution, 
resulting in a final DMSO concentration of approximately 10 %. The cryovials were 
wrapped in paper towels, cooled down in a -80°C freezer and then frozen in liquid 
nitrogen to be finally stored in a cell bank over liquid nitrogen. 
 
 
4.2.1.5. Cultures of the human hepatocellular carcinoma cell line 
HepG2 
 
Starting of the culture 
Frozen HepG2 cells, purchased from ATCC via LGC Promochem, were thawed at 
37°C in a waterbath. The tube content was then transferred to an 80 cm2 culture flask 
filled with 30 mL 90 % DMEM / 10 % FCS / antimycotic followed by an incubation at 
37°C in an atmosphere containing 10 % CO2 (in air) for 6 h. After that time the cells 
were attached to the culture dish and the medium was renewed. 
 
Maintenance of the cell culture  
HepG2 cells were cultured in 80 cm2 culture flasks using 90 % DMEM / 10 % FCS / 
antimycotic as the culture medium in an atmosphere containing 10 % CO2. The 
medium was renewed every fourth day. 
 
Passaging of the cells 
The cells were passaged as described for A9 fibroblasts in 4.2.1.4. However, the 
trypsin solution contained 0.25 % trypsin and 0.53 mM EDTA in phosphate buffered 
saline (PBS) at pH 7.4. 
 
Preparation of cryostocks 
The cryostocks were prepared as described for A9 fibroblasts in 4.2.1.4. The culture 
medium used was 90 % DMEM / 10 % FCS / antimycotic.  
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4.2.2. Harvesting of rat organs and cells 
 
4.2.2.1. Harvesting of rat organs for RNA isolation and for 
preparation of protein homogenates 
 
Young and adult Wistar rats were anaesthesised with CO2 in a gas chamber and 
subsequently decapitated with a pair of scissors or a guilloutine, respectively. The 
desired organs were dissected out and transferred to a precooled plastic tube, frozen 
in liquid nitrogen and stored at -80°C until further use.  
 
 
4.2.2.2. Harvesting of rat organs for immunohistochemical stainings 
 
Animals were killed as described above. Subsequently, tissues were incubated in     
4 % PFA / PBS at 4°C for 24 h, soaked with 30 % sucrose / PBS at 4°C for 20 h, 
embedded in Neg 50 cryomedium and frozen in isopentane that had been precooled 
by liquid nitrogen until bleb formation. Samples were stored at -80°C. 
 
 
4.2.2.3. Harvesting of cells from culture dishes 35 mm in diameter  
 
Dependent on the experimental requirements, 4-20 culture dishes 35 mm in diameter 
were used. After removal of the culture medium, the cells were washed 3 times with 2 
mL ice-cold PBS. Subsequently, 1 mL ice-cold PBS was pipetted into the first dish 
and the cells were scraped off with a rubber policeman. The resulting suspension 
was sequentially transferred to a second, third, etc. culture dish from which the 
medium had been removed and that had been washed with PBS, and the cells were 
again scraped off after each transferral. The suspension coming from the last dish 
was finally pipetted into a 1.5 mL reaction tube and centrifuged at 3000 rpm and 4°C 
for 5 min in a table top centrifuge. The supernatant was discarded and the pellet was 
stored at -20°C until experiments were conducted. 
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4.2.2.4. Collecting of cells grown in 80 cm2 culture flasks 
 
Cells were trypsinised as described in 4.2.1.4. After centrifugation the pellet was 
resuspended in 1 mL HBSS. After an additional centrifugation at 5000 rpm and 4°C 
for 5 min in a table top centrifuge, the supernatant was discarded and the pellet was 
stored at -80°C. 
 
 
4.2.3. Preparation of homogenates 
Homogenisation buffer: 50 mM Tris/HCl, 1mM EDTA; pH 7.4 
4.2.3.1. Preparation of homogenates from rat organs 
 
Frozen rat organs (obtained as described in 4.2.2.1.) were weighed and transferred 
to ice-cold homogenisation buffer (50 µL buffer per 10 mg tissue). Subsequently, the 
organs were homogenised by a Branson sonifier (output control 2, duty cycle 50 %, 
approximately 100 pulses). During sonication the samples were permanently kept on 
ice. Lysates were cleared by two sequential centrifugations (13000 rpm, 4°C, 15 min) 
in a table top centrifuge. The pellet was discarded and the protein-containing 
supernatant was frozen at -20°C until further use. 
 
 
4.2.3.2. Preparation of homogenates from cultured cells 
 
Cells harvested as described in 4.2.2.3. and 4.2.2.4., respectively, were resuspended 
in homogenisation buffer in a 1.5 mL reaction tube. A pellet of approximately 1 mm 
thickness was suspended in 150 µL homogenisation buffer. From thereon, the 
procedure was identical to the one described in 4.2.3.1. 
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4.2.4. Preparation of cryosections from rat tissues 
 
Tissues were obtained as described in 4.2.2.2. Frozen tissues were cut into 10 µm 
thin sections in a cryostat at -25°C and transferred to “Superfrost” microscopic slides. 
After air drying, sections were stored at -80°C until further use. 
 
 
4.2.5. Subtracted ependymal cDNA libraries 
 
4.2.5.1. Generation of a subtracted ventricular ependymal cDNA 
library and a subtracted bovine subcommissural cDNA 
library 
 
All kits employed for library construction were used according to the respective 
manufacturer’s instructions. 
 
Freshly slaughtered cows were decapitated in the local abattoir. The skulls were 
skinned and opened by cutting off the occipital part under a hydraulic guilloutine. 
Care was taken not to crush the brains in the process. The brains were removed 
through the opening, and the lateral ventricles were carefully opened by cutting with 
a scalpel. The ependymal layer was scraped off the ventricular walls with a curve-
bladed scalpel and stored in ice-cold HBSS. Additionally, the SCOs were dissected 
out and also stored in ice-cold HBSS until further use (within 6 h of the deaths of the 
animals). PolyA RNA was obtained from the prepared tissue with “RNeasy” RNA 
isolation kits. A RT reaction, using the SMARTTM PCR cDNA synthesis kit, and a 
subsequent cDNA amplification by the Advantage® 2 PCR system were performed to 
obtain “tester” cDNA. “Driver” cDNA was generated from ependyma-free bovine brain 
tissue of the cortical region by the same method. The further procedure was 
performed with the PCR SelectTM cDNA subtraction kit according to the principle of 
suppression subtractive hybridization described by Diatchenko et al. (1996). The 
subtracted SCO cDNA library was constructed by the same procedure with “tester” 
cDNA generated from SCO RNA. 
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4.2.5.2. Screening of subtracted ependymal cDNA libraries 
 
Subtracted libraries were screened with a dot blot array, following the protocol 
supplied with the PCR-Select differential screening kit. Putative differentially 
expressed sequences were sent to SeqLab Laboratories, Göttingen, for commercial 
sequencing. 
 
 
4.2.6. Other molecular biology techniques 
 
4.2.6.1. Preparation of medium for bacterial liquid cultures 
 
LB powder (20 g) was dissolved in 1 L ddH2O with the aid of a magnetic stirrer and 
subsequently autoclaved at 121°C for 15 min. After the liquid had cooled down to 
approximately 50°C, 1 mL of a 1000-fold concentrated antibiotic stock solution was 
added to the medium. LB  medium was stored at 4°C. 
1000-fold concentrated carbenicillin stock solution: 50 mg/mL 
1000-fold concentrated kanamycin stock solution: 50  mg/mL  
 
 
4.2.6.2. Preparation of agar plates 
 
Preparation of selection plates was performed according to 4.2.6.1., but 30 g LB agar 
were used instead of LB. After autoclaving and addition of the antibiotic stock 
solution, the liquid was distributed among Petri dishes under sterile conditions. When 
the agar had hardened, the plates were stored at 4°C.  
 
 
4.2.6.3. Bacterial liquid cultures 
 
In order to amplify bacterial clones for plasmid isolation, bacterial liquid cultures were 
prepared. For this, bacteria from a streakout were transferred to 5 mL of antibiotic- 
containing LB medium via a sterile toothpick. Subsequently, liquid bacterial cultures 
were incubated overnight at 37°C on a shaker platform. 
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4.2.6.4. “Mini” scale preparation of plasmid DNA from bacterial 
liquid cultures 
 
Bacterial liquid overnight cultures (4.2.6.3.) were centrifuged in a Heraeus/Christ 
Varifuge K (3000 rpm, 4°C, 15 min). The supernatant was discarded and plasmid 
DNA was isolated from the bacterial pellet with the QIAprep Spin miniprep kit 
according to the manufacturer’s instructions. The amount of isolated DNA was 
measured photometrically as described in 4.2.6.6. 
 
 
4.2.6.5. Preparation of bacterial glycerol stocks 
 
For preparing bacterial glycerol stocks, 0.5 mL of a bacterial overnight culture and 0.5 
mL glycerol were mixed; the resulting suspension was then frozen in liquid nitrogen 
and stored at -80°C. 
 
 
4.2.6.6. Photometric determination of nucleic acid concentration 
 
The concentration of DNA or RNA solution was determined photometrically. For this, 
the absorbance (OD) was measured at a wavelength of 260 nm. The solvent in which 
the sample was diluted was used as a reference (blank). An OD260 value of 1 
corresponded to a concentration of 50 µg/mL for double stranded DNA, and to 40 
µg/mL for RNA. The dilutions were prepared in such a way that the absorbance fell 
into the range from 0.1 to 1, assuring linear correlation between nucleic acid 
concentration and absorbance. The sample volume was 10 µL. To estimate purity of 
samples, the OD260/OD280 ratio was calculated. A protein-free nucleic acid solution 
was assumed to display a ratio of 1.8 up to 2.0.  
 
 
4.2.6.7. Cloning of the Wdr16 PCR product into the pDNR-1r vector 
 
Total cellular RNA was isolated from EPCs with the RNeasy RNA isolation kit 
according to the manufacturer’s protocol. One microgram of total RNA was mixed 
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with 1 µL RNasin (40 U/µL) and 1 µL oligo(dT15) adapter primer (500 µg/mL). The 
reaction volume was filled up to 12 µL with ddH2O and incubated at 70°C for 10 min. 
After brief chilling on ice, the following components were added: 1 µL RNasin (40 
U/µL), 2 µL 10-fold concentrated Omniscript buffer RT, 2 µL DTT (0.1 M), 1 µL dNTP 
(10 mM each) and 1 µL ddH2O. The tube content was incubated at 42°C for 2 min. 
After addition of 1 µL Omniscript RT (4 U/µL), the reaction was further incubated at 
42°C for 50 min to facilitate reverse transcription. The enzyme was heat-inactivated 
at 95°C for 5 min, the reaction tube briefly chilled on ice, and the cDNA was stored at 
-80°C until further use. 
 
For amplification of Wdr16 cDNA, the High Fidelity PCR Enzyme Mix was used. For 
this, 1 µL of cDNA was mixed with 5 µL 10-fold concentrated High Fidelity PCR 
buffer, 2 µL primer mix (10 µM each), 5 µL dNTPs (2 mM each) and 0.25 µL High 
Fidelity enzyme mix (5 U/µL). The reaction volume was brought to 50 µL with ddH2O. 
The PCR primers bore restriction sites for BamHI and HindIII, respectively, and had 
the sequences 5’-GCATACGGATCCGCATGGAAGAACAAATTTTACCCGAGACC-3’ 
and 5’-GCATACAAGCTTAGCAAATGGGTATTTCCACCTCAAGAT-3’. The cycling 
parameters used were: 94°C, 30 s; 59.3°C, 30 s; 72°C, 2 min 10 s (30 times); final 
elongation (72°C, 10 min). Before thermal cycling, the samples were heated to 95°C 
for 2 min. The PCR product was then purified with the QIAquick PCR purification kit 
according to the manufacturer’s instructions. 
 
The purified Wdr16 PCR product was digested with Hind III (4.2.6.9.) followed by a 
phenol / chloroform / isoamyl alcohol extraction with subsequent ethanol precipitation 
(4.2.6.10.) and was finally cut with BamHI (4.2.6.9.). The pDNR-1r vector DNA was 
digested under identical conditions with HindIII / BamHI and dephosphorylated with 
CIAP (4.2.6.11.) in order to prevent vector self-ligation in the subsequent ligation 
reaction.  
 
The digested Wdr16 PCR product as well as the pDNR-1r vector DNA were purified 
by preparative agarose gel electrophoresis (4.2.6.12.). The desired bands were cut 
out from the agarose gel (4.2.6.13.), and DNA was isolated with the QIAquick gel 
extraction kit according to the manufacturer’s instructions. 
 
Materials and methods 
82  
pDNR-1r vector DNA and the amplified Wdr16 PCR product were ligated using T4 
ligase (4.2.6.14.), transferred into NovaBlue SinglesTM competent cells (4.2.6.16.) 
and transformed cells were selected on carbenicillin-containing agar plates. The 
streak-outs of these colonies were used as a source to start bacterial liquid cultures, 
from which the recombinant plasmid DNA was isolated with the QIAprep Spin 
miniprep kit according to the manufacturer’s protocol. The isolated recombinant 
plasmid DNA was subjected to two individual restriction digestions with EcoRI and 
EcoRV, respectively, and analysed on an analytical 1.2 % agarose gel. The plasmids 
showing the expected restriction pattern were commercially sequenced by SeqLab 
Laboratories, Göttingen, Germany. One of the bacterial clones bearing the mutation-
free recombinant plasmid was used to prepare a bacterial glycerol stock that was 
stored frozen at -80°C. 
 
 
4.2.6.8. Cloning of the Wdr16 PCR product into the pEGFP-N1 
vector 
 
For amplification of the Wdr16 insert, the pDNR-1r/Wdr16 recombinant vector was 
used as a template instead of cDNA. This allowed for a lower number of cycles in the 
PCR reaction, which in turn reduced the likelyhood of point mutations in the 
amplification process. 
 
For amplification of the Wdr16 insert, the SAWADY Pwo-DNA-Polymerase kit was 
used. For the PCR reaction, two master mixes were prepared. Master mix I contained 
5 ng pDNR-1r/Wdr16 recombinant vector DNA, 2 µL dNTPs (10 mM each) and 6 µL 
primer mix (10 µM each). It was filled up with ddH2O to a total volume of 50 µL. 
Master mix II contained 10 µL 10-fold concentrated complete reaction buffer, 2.5 µL 
Pwo polymerase (1 U/µL) and 37.5 µL ddH2O. The cloning primers bore restriction 
sites for BamHI and XhoI, respectively, and had the sequences 5’-
GCATACCTCGAGATGGAAGAACAAATTTTACCCGAGACC-3’ and 5’-
GCATACGGATCCCGAGCAAATGGGTATTTCCACCTCAAGAT-3’. Both master 
mixes were heated to 94°C for 2 min separately from each other, before they were 
combined to commence amplification. The cycle parameters used were: 94°C, 30 s; 
55°C, 30 s; 72°C 2 min 10 s (13 times); final elongation (72°C, 7 min). 
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The further cloning procedure followed the protocol described in 4.2.6.7. with the 
following modifications: pEGFP-N1 vector and the Wdr16 PCR product were both 
digested in a double digestion reaction with BamHI and XhoI. After ligation, DH5α 
competent cells were transformed with the recombinant pEGFP-N1/Wdr16 vector 
DNA and streaked out for selection on kanamycin-containing agar plates. In order to 
verify the cloned vector, bacterial clones were multiplied in kanamycin-containing 
bacterial liquid medium, and an analytical digestion was performed with PvuII. 
 
 
4.2.6.9. Cutting of DNA with restriction endonucleases 
 
Preparative digestion of vector DNA and PCR product 
Three to four milligrams vector DNA or a PCR product that had previously been 
purified with the QIAquick PCR purification kit according to the manufacturer’s 
instructions (eluted with 44 µL H2O), respectively, were digested with 10 U of the 
corresponding restriction enzymes in the appropriate buffers for 4 h. The total 
reaction volume was 50 µL. 
 
 
Analytical digestion of recombinant DNA 
Five hundred microgams of the recombinant plasmid DNA were digested with 10 U of 
the corresponding restriction enzymes in the appropriate buffers for 2 - 4 h at 37°C 
according to the advice of the manufacturer. The total reaction volume was 50 µL. 
 
If a sequential digestion was necessary, a phenol / chloroform / isoamyl alcohol 
extraction with subsequent ethanol precipitation (4.2.6.10.) was performed after 
digestion with the first restriction enzyme. The extracted and precipitated DNA was 
subsequently subjected to the digestion with the second restriction enzyme.  
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4.2.6.10. Phenol/Chloroform/Isoamyl alcohol extraction of DNA with 
subsequent ethanol precipitation 
 
DNA solution was mixed with 1 volume phenol / chloroform / isoamyl alcohol  (25 : 24 
: 1, v / v), vortexed and centrifuged (13000 rpm, RT, 5 min) in a table top centrifuge. 
The upper, aqueous, DNA-containing phase was transferred to a new 1.5 mL 
reaction tube and combined with 3 volumes of pure ethanol. The DNA was allowed to 
precipitate for 2 h at -20°C. After centrifugation (13000 rpm, 10 min), the pellet was 
washed with 80 % ethanol, dried briefly and dissolved in 44 µL ddH2O, before it was 
finally subjected to a further restriction digestion with another enzyme.  
 
 
4.2.6.11. Dephosphorylation of vector DNA 
Dephosphorylation buffer: 500 mM Tris/HCl, 1 mM EDTA; pH 8.0 
 
Experimental procedure 
Five microliters dephosphorylation buffer and 0.5 µL CIAP (70,0000 U/ml) were 
added to 50 µL of the restriction digestion reaction, followed by an incubation at 37°C 
for 1h. Subsequently, the enzyme was heat-denatured at 80°C for 10 min. 
 
 
4.2.6.12. Agarose gel electrophoresis 
 
Solutions 
50-fold concentrated TAE: 2 M Tris, 0.1 M EDTA, Na salt; pH 8.5 (pH was adjusted  
    with glacial acetic acid) 
5-fold concentrated DNA loading buffer: 40 % (w/v) sucrose, 0.25 % (w/v)  
       bromophenol blue 
 
Experimental procedure 
Agarose gel electrophoresis was used for analytical purpose as well as for 
preparative DNA purification. Agarose concentrations varied between 1.0 % and      
1.2 %, depending on the expected size of the DNA fragments. Agarose was 
dissolved in 50 mL of TAE by heating the mixture in a microwave oven. After cooling 
down to approximately 50°C the solution was poured into a gel slide (110 x 90 mm). 
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A gel comb was then placed into the tray to generate gel pockets. The samples were 
mixed (5 : 1) with 5-fold concentrated DNA loading buffer. The samples were heated 
to 65°C for 5 min, chilled on ice and briefly centrifuged in a table top centrifuge to 
collect the condensate. Electrophoresis was conducted at 100 V in TAE buffer (550 
ml) for approximately 1.5 h. “PeqGold 100 bp Plus DNA ladder” or “1 kb plus DNA 
ladder” were used as size standards. To visualise nucleic acids, the gels were 
incubated in 0.005 % (v/v) ethidium bromide / TAE for 10 min and then inspected on 
a UV transluminator. Photographs were taken with a digital camera. For preparative 
purpose, gels were processed as described in 4.2.6.13. 
 
 
4.2.6.13. DNA extraction from preparative agarose gels 
 
DNA from one sample was loaded into two adjacent lanes of an agarose gel. The 
lane placed next to a DNA standard, named the analytical lane, contained a lower 
volume than the preparative lane from which the DNA was to be extracted later on. 
After gel electrophoresis (4.2.6.12.), the part of the gel containing the marker lane 
together with the analytical lane was cut off with a scalpel and stained with 0.005 % 
ethidium bromide / TAE for 10 min. The desired band in the analytical lane was 
marked by cutting it out under UV illumination. Afterwards, the analytical lane was 
again aligned precisely to the preparative lane of the gel in order to facilitate the 
cutting out of the desired band from the preparative lane. Isolation of DNA from the 
agarose fragment was accomplished by the QIAquick gel extraction kit according to 
the manufacturer’s protocol. The amount of isolated DNA was measured 
photometrically as described in 4.2.6.6. 
 
 
4.2.6.14. Ligation of PCR fragments into vector DNA 
 
Based on 25 ng vector DNA, a 5-fold molecular excess of insert DNA was used for 
the ligation reaction. The corresponding amount of insert was calculated with the 
equation: 
AmountInsert= 125 ng Vector x lengthInsert (bp) / lengthVector (bp). 
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Twenty five nanograms vector DNA and the corresponding amount of insert DNA 
were supplemented with 1 µL 10-fold concentrated MBI ligation buffer and 1 µL T4-
ligase (5 U/µL). The reaction mixture was then filled up to a total volume of 10 µL with 
ddH2O. The ligation reaction was incubated overnight at 16°C. The next day, the 
enzyme was inactivated at 65°C for 10 min. 
 
 
4.2.6.15. Preparation of E. coli DH5α competent cells 
 
Solutions 
TFB I buffer: 30 mM potassium acetate / 100 mM RbCl2 / 10 mM CaCl2 / 
  50 mM MnCl2/ 15 % (v/v) glycerol;  pH 5.8 
TFB II buffer: 10 mM MOPS / 10 mM RbCl2 / 75 mM CaCl2 / 15 % (v/v) glycerol;  
   pH 7.0 
 
Experimental procedure 
E. coli DH5α cells were kindly provided by F. Madeo as an agar plate streakout. 
Starting from the streakout, a 5 mL bacteria liquid overnight culture was started in 
antibiotic-free LB medium. For preparation of competent cells, 500 mL antibiotic-free 
LB medium were inoculated with 1 mL of the overnight culture and incubated on a 
shaking platform at 37°C until the bacteria suspension reached an OD of 0.5 at a 
wavelength of 595 nm. Afterwards, the cells were spun down in a Heraeus/Christ 
Varifuge K (3000 rpm, 4°C, 15 min). The resulting pellet was resuspended in 150 mL 
TFB I buffer, incubated 15 min on ice and centrifuged again under the 
aforementioned conditions. Subsequently the pellet was dissolved in 20 mL TFB II 
buffer. Finally, 100 µL aliquots of DH5α competent cells were frozen in liquid nitrogen 
and stored at -80°C until further use. 
 
 
4.2.6.16. Transformation of competent bacterial cells with plasmid 
DNA 
 
Transformation of NovagenBlue SinglesTM competent cells 
E. coli NovagenBlue SinglesTM competent cells were thawed on ice, mixed carefully 
with 1.5 µL of the ligation solution (4.2.6.14.) and incubated on ice for 5 min. 
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Subsequently the cells were heat-shocked at 42°C for 30 s. After incubation on ice 
for 2 min, the cells were mixed with 250 µL SOC medium (provided with the cells) 
and incubated at 37°C for 1 h on a shaking platform. Volumes of 50 - 120 µL were 
streaked out on antibiotic-containing agar plates, and the plates were incubated 
overnight at 37°C. On the next day, the plates were checked for the presence of 
colonies. 
 
Transformation of DH5α cells made competent according to 4.2.6.15 
E. coli DH5α competent cells were thawed on ice, carefully mixed with 10 µL of the 
ligation solution (4.2.6.14.) and kept on ice for 10 min. The heat-shock was 
conducted at 42°C for 2 min. Afterwards, 900 µL antibiotic-free LB medium were 
added, and the suspension was incubated at 37°C for 1 h on a shaking platform. The 
process was continued as described for the transformation of NovagenBlue 
SinglesTM competent cells .  
 
 
4.2.7. Bioinformatic tools 
 
Sequences were compared to the sequence databases at 
http://www.ncbi.nlm.nih.gov/ by BLASTN and TBLASTN. Protein motif scan was 
carried out at http://smart.embl-heidelberg.de/ and 
http://www.ebi.ac.uk/InterProScan/. Tertiary structure prediction was performed at 
http://www.sbg.bio.ic.ac.uk/~phyre/. Gene reports were compiled at 
http://harvester.embl.de. Protein characterisation was performed at http://genome-
www.stanford.edu/source. Phylogenetic and molecular evolutionary analyses were 
conducted using the MEGA software version 3.1 (Kumar et al. 2004). Default 
parameters were used for bioinformatic analyses, unless indicated otherwise. 
 
 
4.2.8. Reverse transcriptase reaction 
 
Total RNA was isolated with the RNeasy RNA isolation kit according to the 
manufaturer’s advice. The reaction mixture for RT of RNA contained 5 mM MgCl2, 10 
mM each of dATP, dGTP, dCTP and dTTP, 25 U AMV RT, 0.625 µg oligo(dT15) 
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adapter primer, 0.625 µg random hexamer primer and 1 µg total RNA in 50 µL of  
PAN Script NH4 buffer. After pipetting on ice, the mixture was heated to 42°C, 
incubated for 1h, inactivated by heating to 95°C for 5 min, diluted 1 : 2 with H2O and 
stored frozen at -80°C. For control purposes, the process was repeated without 
addition of RT. 
 
 
4.2.9. Conventional RT-PCR  
 
RT-PCR for analysis of the wdr16 transcription profile 
One microliter of cDNA (obtained as described in 4.2.8.) was mixed with 12.5 µL 
HotStarTaq master mix, 1 µL primer mix (10 µM each) and 10.5 µL H2O to give a 
total volume of 25 µL. The sequences of the PCR primers used were  
 
target sequence 
Wdr16 5’-CCAGGTGCCGAGATGAGATGTTTGTC-3’ 
5’-TCCTCGGAGCGTGATAGAAGTGATGC-3’ 
β-actin 5’-GGGTCAGAAGGACTCCTACG-3’ 
5’-GGTCTCAAACATGATCTGGG-3’ 
 
The cycling parameters used were 94°C, 30 s; 58°C, 30 s; 72°C, 1 min (30 times); 
final elongation (72°C, 5 min). Before thermal cycling, the polymerase was activated 
by heating the samples to 95°C for 15 min. 
 
RT-PCR for analysis of Wdr16 splice variants 
Two microliters of cDNA (obtained as described in 4.2.8.) were mixed with 12.5 µL 
HotStarTaq master mix, 4 µL primer mix (10 µM each) and 6.5 µL H2O to give a total 
volume of 25 µL. The sequences of the PCR primers spanning intron 2 of Wdr16 
were 5’-TAACGACTAGGAGACGCT-3’ and 5’-CAGCTCCCTCTTCTTAAA-3’. The 
cycle parameters used were 94°C, 30 s; 55°C, 30 s; 72°C, 20s (30 times); final 
elongation (72°C, 10  min). Before thermal cycling, the polymerase was activated by 
heating the samples to 95°C for 15 min. 
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4.2.10. Real-time PCR 
 
Real-time PCR was performed with the FastStart DNA Master SYBR Green I kit 
according to the manufacturer’s instructions. The reaction mixture contained 3 mM 
MgCl2, 0.2 µM of each primer and 2 µL of cDNA (obtained as described in 4.2.8.). 
PCR was carried out in the LightCycler® instrument over 45 cycles under the 
following conditions: denaturation at 95°C for 10 s, step-down annealing (67°-57°C; 
1°/cycle) over 10 cycles and constant annealing temperature of 57°C thereafter for 
10 s, elongation at 72°C for 12 s. The primer sequences were  
 
target sequence 
Wdr16 5’-TGGAATGGCCGACGATGACAGC-3’ 
5’-CCTCGGAGCGTGATAGAAGTGATG-3’ 
Spag 6 5’-TGTACCTACCTACCAGCCCTCGAGC-3’ 
5’-CCTGGCTCTGCTTTTATCTCCTGGA-3’ 
hydin 5’-AACCTGTCCACTTCCAGACCGTTCTT-3’ 
5’-CCACGCTGACTTCAGTGCCACC-3’ 
polaris 5’-GTGAAGAGTGCAGCTGCGACCAA-3’ 
5’-GGGCCTCTTTATAGAACTCAGCTGCCT-3’ 
cyclophilin 5’-GGGGAGAAAGGATTTGGCTA-3’ 
5’-ACATGCTTGCCATCCAGCC-3’ 
 
The specificity of the PCR reaction was verified by melting point analysis and 
agarose gel electrophoresis. To monitor inter-run variability, a standard with a known 
invariant CP was included with each run. To generate the standard, RNA from 3 
different testes and 3 different EPC was reverse transcribed as described in 4.2.8. 
and finally combined, resulting in a total volume of 300 µL as invariant standard. 
 
In order to determine the efficiencies of RT-PCR amplification for different primer 
pairs and RNA sources, a dilution series was prepared from each RNA preparation 
and subjected to real-time PCR analysis. The CPs obtained from these experiments 
were plotted against the logarithms of the respective concentrations (undiluted 
sample set to 1000 arbitrary units) in one diagram per RNA source, and a straight 
line was obtained from these plots by linear regression analysis. The PCR 
amplification efficiencies (E) were then calculated from the slopes of the regression 
lines according to the equation E = 10 (-1/slope). In those cases in which the Wdr16-
specific PCR product could not be obtained from the majority of the diluted solutions, 
the squared linear correlation coefficient (R2) remained below 0.98, indicating that no 
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PCR efficiency was obtainable for the RNA source and that the target Wdr16 mRNA 
had to be assumed to be absent from it. PCR efficiencies derived from regression 
lines with R2 ≥ 0.98 were used to calculate the amounts of Wdr16 mRNA relative to 
that of the mRNA for cyclophilin as the standard according to the formula At/Ac. At = 
Etarget
-CP(+) –Etarget
-CP(-); Ac = Ecyclophilin
-CP(+) – Ecyclophilin
-CP(-) ( +, presence of RT; -, 
absence of RT).    
 
 
4.2.11. Generation of the Wdr16 peptide antibody 
 
For generating a peptide antibody, the peptide with the sequence 
CQAINTNEQNFLHGHGN, corresponding to rat Wdr16 (position 50 - 65), was 
coupled to sulfosuccinimidyl 4-[N-maleimidomethyl]cyclohexane-1-carboxylate-
activated KLH or likewise-activated BSA with the Imject Maleimide Activated 
Immunogen Conjugation kit according to the manufacturer’s advice. The N-terminal 
cysteine of the peptide is not contained in the Wdr16 sequence, but was added as a 
linker amino acid necessary to ensure coupling to the carrier. Immunisation of guinea 
pigs was carried out commercially by Charles River Laboratories, Kisslegg. For the 
initial immunisation and the subsequent boosts (additional injections of the antigenic 
peptide) at day 28 and day 56, 0.1 mg of the KLH-conjugated peptide were injected, 
and final bleeding was carried out at day 70. The BSA-conjugate was stored at -20°C 
until it was used in ELISA experiments. 
 
 
4.2.12. Affinity purification of the Wdr16 antibody 
 
Solutions 
Elution buffer: 100 mM glycine; pH 3.0 (adjusted with HCl) 
Neutralisation buffer: 1 M Tris/HCl; pH 7.5 
 
Experimental procedure 
Four milliliters of the SulfoLink Coupling gel slurry were used to charge a gravity-
flow column resulting in a gel bed volume of 2 mL. Two milligrams of the antigenic 
peptide with the sequence CQAINTNEQNFLHGHGN were dissolved in 1 mL 
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Coupling buffer (provided with the kit), loaded onto the column and coupled to the gel 
matrix via its sulfhydryl groups in a batch procedure. Afterwards, 1.5 mL of the Wdr16 
antiserum (4.2.11.) were applied to the peptide-coupled column and the Wdr16 
antibody bound to the immobilised peptide was eluted with 8 mL elution buffer. The 
eluate was collected in 1 mL fractions that were neutralised with 100 µL 
neutralisation  buffer. For details refer to the instructions manual provided with the 
SulfoLink Coupling gel kit.    
 
 
4.2.13. ELISA to determine antibody titer 
 
Solutions 
Borate buffer:  100 mM boric acid, 25 mM borax, 75 mM NaCl,  
     0.01 % NaN3; pH 8.4 
Blocking solution:  1 % BSA in borate buffer                          
Washing buffer:  0.2 % Tween 20 in borate buffer 
Substrate buffer:  100 mM glycine/NaOH, 1 mM MgCl2, 1 mM ZnCl2; pH 10.4  
Substrate solution:  1 mg/mL p-nitrophenylphosphate in substrate buffer 
 
Experimental procedure 
The ELISA was performed in 96 well microtiter plates with round floors. All amounts 
listed below refer to an individual well. 
 
The wells of the microtiter plate were incubated overnight with 250 ng antigen 
dissolved in 100 µL borate buffer at 4°C. After removal of the antigen solution from 
the plate by “beating out”, free binding sites were blocked with 200 µL blocking 
solution at 37°C for 1 h. In the meantime, a dilution series of the corresponding 
antiserum was prepared by diluting in borate-buffer as follows: 1:10, 1: 30, 1:100, 
1:300, 1: 103, 1: 103,5, 1:104, 1: 104,5, 1: 105, 1: 105,5, 1: 106. After the microtiter plate 
had been washed four times with 200 µL washing buffer, the rinsed wells were 
incubated with 100 µL of the diluted antiserum at 37°C for 2 h, washed four times 
with 200 µL washing buffer and subsequently incubated at 37°C for 1 h with 100 µL 
of the secondary antibody (goat anti-guinea pig IgG-AP conjugate, diluted 1 : 1,000 in 
borate buffer). After washing four times with 200 µL washing buffer, 100 µL of 
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substrate solution were added to the vials, followed by an incubation at 37°C for 10 
min. Finally, the product of the enzymatic reaction was measured in an ELISA reader 
at a wavelength of 405 nm.  
 
 
4.2.14. Protein assay (Bradford assay) 
 
The assay was performed according to Bradford (1976) using the commercially 
available Bio-Rad dye reagent concentrate. 990 µL of the diluted (1 : 6 with water) 
reagent were mixed with 10 µL of the sample (prediluted with ddH2O if necessary) 
and incubated at RT for 15 min. Afterwards, 400 µL of the reaction mixture were 
transferred to a 96 well plate and the absorbance was measured at a wavelength of 
595 nm in the ELISA reader. The protein concentrations were calculated from a 
standard curve prepared with BSA. 
 
 
4.2.15. Discontinuous SDS PAGE 
 
SDS PAGE was carried out as described by Laemmli (1970) with the modifications 
by Garfin (1990). 
 
Solutions 
Acrylamide solution: 29.2 % (w/v) acrylamide, 0.8 % (w/v) bisacrylamide  
    (Rotiphorese Gel 30) 
Running gel buffer:  0.5 M Tris/HCl, pH 8.9 
Stacking gel buffer:  1.5 M Tris/HCl, pH 6.8 
Electrode buffer:  25 mM Tris, 192 mM glycine, 0.1 % (w/v) SDS; pH 8.5 
5-fold concentrated sample buffer: 0.16 M Tris/HCl, 4 % (w/v) SDS, 20 % (w/v)  
        glycerol, 0.38 M mercaptoethanol, 
        0.008 (w/v) bromophenol blue; pH 6.8 
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Preparation of the gels  
The gel size was 8 cm x 10 cm x 1 mm. The stacking gels were prepared with 3 % 
acrylamide at pH 6.8, the running gels with 10 % acrylamide at pH 8.9. The following 
scheme was used to cast the gels: 
 
Solution  10 % running gel  3 % stacking gel 
     
Acrylamide solution  3.33 mL  0.50 mL 
Running gel buffer  2.5 mL   
Stacking gel buffer    1.25 mL 
Water  4.05 mL  3.0 mL 
                                                                     Degassing (2 min)  
10 % (w/v) SDS  100 µL  50 µL 
TEMED  20 µL  5 µL 
10 %  (w/v) APS solution  37.5 µL  200 µL 
 
Preparation of the samples  
Protein solution was mixed with 5-fold concentrated sample buffer and filled up with 
ddH2O to give a final concentration of 1-fold sample buffer in a maximal volume of 18 
µL. The mixture was then heated to 95°C for 7 min. After collecting the condensate 
by brief centrifugation, the samples were applied to the gel. 
 
Electrophoresis 
Electrophoresis was carried out under constant current (35 mA) at RT. When the 
bromophenol blue front had reached the end of the running gel, the process was 
stopped. The gels were either stained with Coomassie Brilliant Blue R 250 or used 
for Western blotting. 
 
 
4.2.16. Coomassie staining of polyacrylamide gels 
 
Solutions 
Staining solution:        50 % methanol, 40 % H2O, 10 % glacial acetic acid,  
                          1 % (w/v) Coomassie Brilliant Blue R 250 
Destaining solution:     Methanol : H2O : glacial acetic acid (3 : 6 : 1)  
 
 
 
Materials and methods 
94  
Experimental procedure 
Polyacrylamide gels were incubated with staining solution at RT for 10 min. 
Afterwards, gels were briefly rinsed with water and transferred to destaining solution. 
When the blue background had disappeared and single protein bands became 
visible, the destaining solution was discarded and the gel was washed with ddH2O. 
Protein bands were documented by a digital camera. 
 
 
4.2.17. Western blot analysis with chemiluminescence 
detection 
 
Protein Transfer 
 
Solutions 
Transfer buffer:  25 mM Tris/ HCl, 192 mM glycine; pH 9.0 
Ponceau S solution: 0.2 % (w/v) Ponceau S in 3 % (w/v) trichloroacetic acid 
 
Experimental procedure 
Thirty micrograms of protein homogenate (4.2.3.) were separated by discontinuous 
SDS PAGE (4.2.15.). The protein bands were then transferred from the gel to a 
nitrocellulose membrane using a modification of the protocol described by Burnette 
(1981). 
 
The nitrocellulose membrane was moistened in transfer buffer. The transfer 
“sandwich” was packed by piling a plastic lattice, a synthetic fiber mat, a filter paper, 
the SDS polyacrylamide gel, the nitrocellulose membrane, a filter paper, a synthetic 
fiber mat and a final plastic lattice. Air bubbles were strictly avoided in the process. 
The arrangement was inserted into an electroblot chamber filled with transfer buffer. 
Electrophoretic protein transfer was performed with 140 mA at 4°C for 2 h. 
 
After transfer, the membrane was removed fom the transfer chamber and stained by 
brief immersion in Ponceau S solution. Subsequently the membrane was destained 
with 0.05 % (v/v) Tween 20 / PBS, washed with PBS and processed as described in 
the following. 
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Detection of protein bands with enhanced chemiluminescence (ECL) reagent 
 
Solutions 
Washing buffer: 20 mM Tris/HCl, 150 mM NaCl, 0.02 % (v/v) Tween 20; pH 7.4 
Blocking solution: 1-fold concentrated Roti-Block / PBS 
Substrate solution: 1 mL ECL solution I + 1 mL ECL solution II 
 
Experimental procedure 
The membrane was incubated overnight with 20 mL blocking solution at RT in order 
to block unspecific binding sites. It was then washed three times for 5 min with 20 mL 
washing buffer, and 20 mL of the the guinea pig Wdr16 antiserum (or the 
corresponding preimmune serum) were added at a dilution of 1:10,000 in washing 
buffer. The incubation time was 1 h. The membrane was washed three times for 5 
min with 20 mL washing buffer before 20 mL of the secondary antibody solution were 
applied. The secondary antibody was donkey anti-guinea pig IgG conjugated with 
peroxidase, diluted 1:120,000 in washing buffer. The incubation time was 1 h. The 
membrane was washed again three times for 5 min with 20 mL washing buffer, 
rinsed briefly with PBS and then the ECL detection solution (1 ml per membrane) was 
added to the membrane. After 2 min, the solution was removed, the membrane 
wrapped in transparent plastic foil and an X-ray film was exposed to it for 
approximately 5 min in an exposure cassette. The film was developed in an X-ray film 
developing machine. As a further negative control besides preimmune serum, an 
excess (> 26 µM) of the antigenic peptide against which the antibody had been 
raised was added to the Wdr16 antiserum solution and incubated at RT for 1 h before 
it was applied to the membrane. 
 
As loading controls, replica gels were stained with Coomassie Brilliant Blue, as 
described in 4.2.16. 
 
 
4.2.18. Transfection of A9 fibroblasts 
 
A9 fibroblasts were trypsinised as described in 4.2.1.4. and seeded in 90 % DMEM / 
10 % FCS / PS on 18 mm x 18 mm coverslips that had been placed in culture dishes 
35 mm in diameter. After the cells had proliferated to fill approximately 60 % of the 
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coverslips, the medium was sucked off and replaced by 90 % DMEM / 10 % FCS. 
The cells were transfected with either 2 µg of pEGFP-N1/Wdr16 recombinant vector 
DNA or with pEGFP-N1 vector DNA (control). For this purpose, the DNA was 
combined with 50 µL of 150 µM NaCl solution and was mixed thoroughly with the aid 
of a vortex mixer. In another reaction tube, 6 µL of “JetPEI”-reagent were combined 
with 100 µL of 150 µM NaCl solution and mixed thoroughly with the aid of a vortex 
mixer. Afterwards, the “JetPEI”-containing solution was transferred to the reaction 
tube with the DNA solution, mixed thoroughly and incubated at RT for 15 min. 
Subsequently, the transfection solution was added dropwise to the antibiotic-free 
medium in the culture dishes. After incubation at 37°C for 4 h in an atmosphere 
consisting of 10 % CO2 /  90 % air, the medium was exchanged for fresh 90 % 
DMEM / 10 % FCS / PS. The cells were then incubated under the aforementioned 
conditions until they had grown to confluency on the next day.  
 
 
4.2.19. Immunofluorescent staining 
 
4.2.19.1. Staining of A9 fibroblasts 
 
Solution 
Blocking solution: 10 % goat normal serum / PBS 
 
Experimental procedure 
For staining, A9 fibroblasts were seeded on coverslips (18 mm x 18 mm) that had 
been placed in culture dishes 35 mm in diameter. The culture medium was sucked off 
and the cells on the coverslip were washed three times for 5 min with 2 mL PBS, 
fixed for 10 min with 2 mL 4 % PFA / PBS, washed again three times for 5 min with 2 
mL PBS, incubated for 5 min with 2 mL 0.1 % glycine / PBS and treated with 2 mL 
0.15 % glycine / 0.15 % Triton X-100 / PBS for 10 min. Subsequently, the cells were 
incubated with approximately 100 µL of the guinea pig Wdr16 antiserum or with the 
corresponding preimmune serum that was directly applied to the coverslip at RT for 2 
h. The sera were diluted 1:1,000 in blocking solution. For the peptide competition 
control, the antigenic peptide was added to the antibody solution to a concentration 
of 264 µM and incubated at RT for 1 h. After washing three times for 5 min with 2 mL 
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PBS, approximately 100 µL of the secondary antibody solution were applied directly 
on the cells attached to the coverslip at RT for 1 h. The secondary antibody was a 
goat anti-guinea pig IgG-Alexa 546 conjugate, diluted 1:4,000 in blocking solution. 
After washing three times for 5 min with 2 mL PBS, a drop of DAPI-containing 
Vectashield embedding medium was placed on the coverslip, which was then 
transferred to a microscope slide for inspection. 
 
 
4.2.19.2. Staining of rat tissues 
 
Solutions 
Blocking solution:  0.9 % (v/v) Triton X-100 in Roti-ImmunoBlock 
                                 / PBS; pH 7.4 
 Washing buffer:  0.3 % (v/v) Triton X-100 / PBS; pH 7.4 
 
Experimental procedure 
Frozen tissue sections (for preparation see 4.2.4.) were brought to room temperature, 
equilibrated with 60 mL PBS in a glass staining-cuvette for 2 min and fixed with 60 
mL  4 % PFA / PBS for 10 min. After washing three times for 5 min with 60 mL PBS, 
the remaining PFA was inactivated with 60 mL 0.1 % glycine / PBS for 5 min, and the 
sections were washed again with 60 mL PBS (three times for 5 min), followed by an 
incubation with 60 mL 0.9 % Triton X-100 / PBS for 10 min. Unspecific binding sites 
were blocked with approximately 200 µL blocking solution in a humid chamber at 
37°C for 2.5 h. The blocking solution was applied directly to the tissue sections 
placed on microscopic slides. Subsequently, the tissue was incubated with 
approximately 200 µL of either the affinity-purified guinea pig anti Wdr16 antibody 
solution (4.2.12.) at 37°C for 30 min, or the corresponding preimmune serum 
solution. The dilution of the first antibody was 1:200 in blocking solution. For the 
preabsorption control, the antigenic peptide was incubated at a concentration of 264 
µM with a 1:100 dilution of the Wdr16 antibody in PBS at RT for 1 h. It was 
subsequently centrifuged at high speed in a table top centrifuge, and the supernatant 
was then employed just like the Wdr16 antibody for which it was to serve as the 
control. For the further staining, sections were washed three times for 5 min with 60 
mL washing buffer in a glass staining-cuvette, followed by an incubation with 200 µL 
of the secondary antibody solution that was applied directly to the tissue sections 
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placed on microscopic slides at 37°C for 50 min. The secondary antibody was a 
donkey anti-guinea pig IgG-Cy3 conjugate, diluted 1:1,000 in blocking solution. 
Finally, sections were washed three times for 5 min in a glass staining-cuvette with 
60 mL washing buffer, briefly rinsed in PBS and embedded in a drop of DAPI-
containing Vectashield mounting medium under a coverslip. 
 
For double labellings, two consecutive stainings with in-between fixation were 
performed. Antibodies used for counterstaining of cilia were: monoclonal mouse anti-
α-tubulin (diluted 1:1,000) and goat anti-mouse IgG-Alexa 488 conjugate (1:1,000) or 
rabbit anti-mouse IgG-FITC conjugate (1:2,000). Antibodies used for counterstaining 
of glycogen phosphorylase were: rabbit antiserum against GP BB (1: 1,000) and goat 
anti-rabbit IgG-Alexa 488 conjugate (1:1,000). 
 
 
4.2.19.3. Staining of ependymal primary cultures and astroglial  
         primary cultures 
 
Solutions 
Blocking solution:      0.3 % (v/v) Triton X-100 in Roti-ImmunoBlock 
     / PBS; pH 7.4                        
Washing buffer:  0.1 % (v/v) Triton X-100 / PBS; pH 7.4 
 
Experimental procedure 
After removal of the culture medium, the cells which had been grown on 18 mm x 18 
mm coverslips placed in culture dishes 35 mm in diameter were washed three times 
for 5 min with 2 mL PBS and fixed with 2 mL 4 % PFA / PBS at RT for 10 min. After 
washing three times for 5 min with 2 mL PBS, the remaining PFA was inactivated 
with 2 mL 0.1 % glycine / PBS for 5 min, and the coverslips were washed again with 
2 mL PBS (three times for 5 min), followed by an incubation with 2 mL 0.3 % Triton 
X-100 / PBS for 10 min. Unspecific binding sites were blocked with approximately 
100 µL blocking solution in a humid chamber at 37°C for 2.5 h. The blocking solution 
was applied directly to the cells attached to the coverslip. Subsequently, the cells 
were incubated with approximately 100 µL of either the affinity purified guinea pig anti 
Wdr16 antibody solution (4.2.12.) at 37°C for 30 min, or the corresponding 
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preimmune serum solution. The dilution of the first antibody was 1:200 in blocking 
solution. The coverslips in the dish were subsequently washed three times for 5 min 
with 2 mL washing buffer, followed by an incubation with 100 µL of the secondary 
antibody solution that was applied directly to the cells at 37°C for 50 min. The 
secondary antibody was a donkey anti-guinea pig IgG-Cy3 conjugate, diluted 1:1,000 
in blocking solution. Finally, sections were washed three times for 5 min in the culture 
dish with 2 mL washing buffer and briefly rinsed in PBS. After the staining procedure, 
a drop of DAPI-containing Vectashield mounting medium was placed on the coverslip 
that was finally transferred to a microscope slide for inspection. The peptide 
competition was performed as described in 4.2.19.2.  
 
For double labellings, two consecutive stainings with in-between fixation were 
performed using antibody concentrations as described in 4.2.19.2. 
 
 
4.2.20. Separation of bull sperm into head and tail fractions 
The separation of bull sperm into heads and tails was performed according to Hinsch 
et al. (2003) with the following modifications:  
 
Solution 
Sucrose solution: 250 mM Sucrose, 1 mM EDTA, 25 mM Tris/HCl; pH 7.2 
 
Experimental procedure 
Fourteen milliliters of bull-ejaculate/caprogen solution, provided by M. Lautner, were 
distributed among 14 1.5 mL reaction tubes and centrifuged at 6000 x earth’s 
gravitational acceleration (9.81 m/s2; g) at 4°C for 15 min in an Eppendorf table top 
centrifuge. The resulting supernatant (seminal plasma fraction) was stored at 4°C 
until the end of the separation process, whereas the sperm-containing pellet was 
washed three times with sucrose solution. After each washing step, resuspended 
sperm were spun down again (6000 x g, 4°C, 10 min). The sperm pellet of one 
reaction tube (total sperm fraction) was resuspended in 200 µL PBS and stored at 
4°C until the end of the separation process. The remaining aliquots were 
resuspended in 250 µL sucrose solution each and individually exposed to 12 
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ultrasonic pulses from a Branson sonifier (level 2, output 20 %) to cause separation 
of sperm heads from tails. Subsequently, fractured sperm from two reaction tubes 
were spun down (6000 x g, 4°C, 15 min) and the pellet was resuspended in 200 µL 
PBS (sperm after sonification fraction). The supernatant (supernatant after 
sonification fraction) was also stored at -20°C. The remaining 11 tubes were 
centrifuged at 720 x g and 4°C for 40 s. The resulting supernatant mostly contained 
sperm tails, whereas sperm heads were mainly present in the pellet. The head and 
tail fractions were further enriched as follows. 
 
The head fractions were washed six times with sucrose solution. Contaminating tails 
remained in the supernatant after centrifugation (720 x g, 4°C, 40 s). The tail 
fractions were washed twice with sucrose buffer. Contaminating heads and 
unfractured sperm were collected in the pellet by centrifugation (720 x g, 4°C, 40 s) 
and were discarded. After enrichment, the head as well as the tail fractions were 
pelleted by centrifugation (6000 x g, 4°C, 15 min). The head pellets were suspended 
in 150 µL PBS (head fraction), and the tail pellets were suspended in 500 µL PBS 
(tail fraction). After the separation process, the individual fractions were homogenised 
on ice with 100 sonification pulses using a Branson sonifier (level 2, output 20 %) in 
the following order: seminal plasma, sperm after sonification, total sperm, tails, 
heads. The homogenates were cleared by centrifugation at 13600 x g and  4°C for 15 
min. The protein content was determined in the resulting supernatant as described in 
4.2.14. The protein solution was used in Western blot experiments as described in 
4.2.17. Before lysis, a 7 µL aliquot was withdrawn from each individual fraction and 
transferred to a coverslip, where the separation quality was assessed under a phase 
contrast microscope. Photomicrographs of each individual fraction were taken with a 
digital camera.  
 
 
4.2.21. Analysis of Wdr16 in zebrafish embryos 
 
These experiments were conducted in the laboratory of Hans Martin Pogoda at the 
Max Planck Institute of Immunobiology in Freiburg.  
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4.2.21.1. Green fluorescent protein fusion control experiment 
 
Solution 
Danieu’s buffer: 58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM Ca (NO3)2, 
                          5 mM HEPES; pH 7.6 
 
Experimental procedure 
To obtain a wdr16/ gfp fusion protein, a 527 bp fragment of Wdr16 encompassing the 
antisense morpholino target sequence was amplified from 24 hpf RNA by RT-PCR. 
Primers were 5’-TCGGATCCCGATTCATAGTCTGAAGCTG-3’ and 5’-
CGTCTAGAGTTGGTGTACTCTAAGGCGA-3’. The PCR product was cloned via 
BamHI / XbaI sites into the XLT.GFPTL-CS2 vector (gift from the laboratory of R. 
Moon, Seattle, USA). Capped mRNA of wdr16/gfp was prepared using the Message 
Machine kit (Ambion) following the manufacturer’s instructions after plasmid 
linearisation with Acc651. wdr16/gfp RNA (25 ng/µL) was coinjected into zebrafish 
embryos together with wdr16MO (0.66 pmol/nL in Danieu’s buffer) and wdr16CoMo 
in volumes of 1 to 1.5 nL, respectively. Treated embryos were assayed for GFP 
expression using fluorescence microscopy at mid gastrulation stages. 
 
4.2.21.2. Procedure of Wdr16 knockdown 
 
Solution 
Danieu’s buffer: 58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM Ca (NO3)2, 
                          5 mM HEPES; pH 7.6 
 
Experimental procedure 
The antisense morpholino for Wdr16 (5’-CTTGTGTGTCTTCTGCCATCGTGAT-3’) 
and the corresponding inverse control morpholino (5’-
TAGTGCTACCGTCTTCTGTGTGTTC-3’) were obtained from Gene Tools Inc. and 
diluted in Danieu’s buffer to a final concentration of 0.066 pmol/nL. Both morpholinos 
were injected in volumes of 1 to 1.5 nL into zebrafish embryos at the one cell stage 
as described by Nasevicius and Ekker (2000). 
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4.2.21.3. Analysis of ciliary beating 
 
Ciliary beat was observed through an Axiovision 2 microscope (Zeiss, Oberkochen) 
and recorded by a Lumenera Lu170 highspeed camera connected to a PC. 
Recorded movies of ciliary beat were played in slow-motion and the beat frequency 
determined by direct visual counting. 
 
 
4.2.21.4. In-situ hybridisation 
 
To generate a DIG-labelled antisense RNA probe for Wdr16, the same fragment 
used for the GFP fusion construct (4.2.21.1.) was cloned into the pGMTeasy vector 
(Promega). The orientation of the insert was determined by sequencing, followed by 
linearisation with BamHI and in vitro transcription using T7 RNA polymerase. 
Detection of Wdr16 mRNA in whole mount zebrafish embryos by in-situ hybridisation  
was carried out according to Westerfield (2000). 
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6.Summary 
 
• Screening of a subtractive ependymal cDNA library of ependyma minus brain and 
subcommissural organ minus brain revealed the wdr16 gene to be specifically 
transcribed in ependymal cells. 
• Wdr16 is a WD40-repeat protein with two predicted covalently linked 7-bladed β-
propellers. 
• Wdr16 is evolutionary conserved and restricted to kinocilia-possessing organisms 
• The rat ortholog is highly expressed in testis and ependymal primary culture as 
shown by Western blot analysis. 
• RT-PCR studies demonstrate abundant transcription of the rat wdr16 gene in 
testis and ependymal primary culture, moderate Wdr16 mRNA levels in lung and 
brain, whilst kinocilia-free tissues are completely devoid of the Wdr16 message. 
• In testis as well as in ependymal primary culture, levels for wdr16 transcript 
increase at approximately the same time and with practically identical time 
courses as the mRNA for the central apparatus constituent sperm-associated 
antigen 6 and the protein restricted to ciliated cells and associated with 
hydrocephalus, hydin. 
• The expression of wdr16 is tied to the formation of kinocilia, as demonstrated for 
testis, ependymal primary culture and the respiratory epithelium. 
• In-situ hybridisation experiments in zebrafish indicate that the gene orthologous to 
wdr16 is only transcribed in kinocilia-expressing cells. 
• Blocking the translation of Wdr16 mRNA in zebrafish embryos via antisense 
morpholinos results in the generation of hydrocephalus, while the ependymal 
morphology and the ependymal ciliary beat remain unaltered. 
• Wdr16 can be considered as a protein that is exclusively expressed in kinocilia-
bearing cells, and therefore, considered as a marker for differentiated ependymal 
cells. 
• The physiological relevance of Wdr16 may lie in the generation and/or 
maintenance of epithelial cell polarity. 
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